Delivered-To: tjphuhs@gmail.com
Received: by 2002:adf:f50b:0:b0:439:567a:e7b2 with SMTP id q11csp414000wro;
        Fri, 27 Feb 2026 15:08:32 -0800 (PST)
X-Received: by 2002:a05:620a:7006:b0:8ca:d5cb:6844 with SMTP id af79cd13be357-8cbc8df1ea3mr643413085a.49.1772233711747;
        Fri, 27 Feb 2026 15:08:31 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1772233711; cv=none;
        d=google.com; s=arc-20240605;
        b=RIIR0rvt3UGjhqPFFyjIc7vqE8LzI7gXOd/kM2GDnrj0ZxL/WA9m4s+9Oul0Q+PRSf
         xMv/b/CmuQGFIXYQp3ScTJy6DJwpeLbGSyg0x5nh2SIQ0lsF4XJaFSMBRwyf1ZZCJ/K1
         h6LMG2SRrXo1C1t04TBvmvu5xJxbyh2lAOG4jNzDjWeBGGkV1xa+kS1i7GbDKQA03VWD
         ooOnmZ7KNZ9Fyf4opP30JB0W5cRVLR0w9L4ek5i1Gip9IQRYlZ5O1sniGDnsDyPGABil
         SK+GKoXE0prGaw8hmvwrxwvTJFqxocMfbFPFj1Ke+Lb45Wl4P9qUnkO4fZwTtYz7VgOo
         aD/g==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605;
        h=to:sid:list-unsubscribe-post:list-unsubscribe:feedback-id:reply-to
         :subject:message-id:mime-version:from:date:dkim-signature
         :dkim-signature;
        bh=wUaIDtNkBtRyvCFq6c5pnF3eCiwd+wVaBEK46cugmGs=;
        fh=Hcu5VqhndQNvtVhwbc8tr7JrSOSQJms/+lG2L+E9gBs=;
        b=SysB2BomkH72zTRMsJ7U28vOON+loIQGt3xVssMBZEV0+zz3oSXYQtPl8WLIstpC/a
         aYY9Uwoj1gr8J3A+3GvFjKMes3G26kgoIKndxvL+rs8l7UbxCZ/3fwbEc4uRGf+kKfrb
         ax3nFVsubapw+fmuPqS1/06Nf9K9OURFKqokc89CcqLIEAEaOZejpyyAvZGP90ulyOfG
         avx9ixkeDkqB8UHtzeKPp/rXhPgKWfCxNbPs7PcbLlURT+PJ9ScYQmYBIAuoUqEGCxya
         KZXt/mAx9aE6fqKn8KTPu7p9AO62sYqvuptvBlroEAdrzNwcPB7d4P3TSjKtPH2uE9oN
         DN3Q==;
        dara=google.com
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@mail.beehiiv.com header.s=s1 header.b=E2mKhgsS;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=YLwG3HII;
       spf=pass (google.com: domain of bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com designates 159.183.140.223 as permitted sender) smtp.mailfrom="bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com";
       dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com
Return-Path: <bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com>
Received: from o168.ptr7383.mail.beehiiv.com (o168.ptr7383.mail.beehiiv.com. [159.183.140.223])
        by mx.google.com with ESMTPS id af79cd13be357-8cbbf731c31si652626685a.389.2026.02.27.15.08.31
        for <tjphuhs@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Fri, 27 Feb 2026 15:08:31 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com designates 159.183.140.223 as permitted sender) client-ip=159.183.140.223;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@mail.beehiiv.com header.s=s1 header.b=E2mKhgsS;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=YLwG3HII;
       spf=pass (google.com: domain of bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com designates 159.183.140.223 as permitted sender) smtp.mailfrom="bounces+38707395-e426-tjphuhs=gmail.com@em2003.mail.beehiiv.com";
       dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=mail.beehiiv.com;
	h=content-type:date:from:mime-version:subject:reply-to:feedback-id:
	list-unsubscribe:list-unsubscribe-post:to:cc:content-type:date:feedback-id:from:
	subject:to;
	s=s1; bh=wUaIDtNkBtRyvCFq6c5pnF3eCiwd+wVaBEK46cugmGs=;
	b=E2mKhgsSHRXpUmIaoFCRro90wdNG/aictrjk5IP4Mfbf/zVMBuwRoDgMv8UYJ9WqFnPN
	AEnuX+mCVgv2O7wfL3IZbOq8wg6Nh714Q4OpHwkUR5f92e7vf9cFRmDx1methrDeSRG66Z
	K14M8NMf/Ly4UTyL+a3STJn5cJDH4d28Ucx6smwfeuglw0YOq2r4zhhwvIrNgxv5iFYvnV
	nuGuJKvoqB/S1YCzDVinpd4sOo0vJq3rn93o+9Ny6bw1tOQF68I0Tfa3TC75m5s8pzsCV4
	/SdiHN/pABkrvl2UNe9HYEPKwfbcVrYYJ+Q/qm2tXwD0DE+Zb2DimwU1+h8Ak2Kg==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:date:from:mime-version:subject:reply-to:feedback-id:
	list-unsubscribe:list-unsubscribe-post:to:cc:content-type:date:feedback-id:from:
	subject:to;
	s=smtpapi; bh=wUaIDtNkBtRyvCFq6c5pnF3eCiwd+wVaBEK46cugmGs=;
	b=YLwG3HIIhws4CVN7B8gnOQVSZiUWM+J++VEL6yR7zS1nK3tC9Zk9KVDDim3ReCi2J44Y
	3qIG5GrzD4rArPSsdbnpCR2o3NG/RNYrNs/kspdsLRRGLKsKnsw0IjGC0A0Z0wbimMh9Ka
	QSvN68NLho1lRnrmP95SygXUlsp7BmX6w=
Received: by recvd-cc7dcf685-spx5v with SMTP id recvd-cc7dcf685-spx5v-1-69A223E5-B6
	2026-02-27 23:08:21.939324568 +0000 UTC m=+6224374.824395883
Received: from Mzg3MDczOTU (unknown)
	by geopod-ismtpd-7 (SG) with HTTP
	id h52gZ3J6QdiZ_-TDlxfDGQ
	Fri, 27 Feb 2026 23:08:21.914 +0000 (UTC)
Content-Type: multipart/alternative; boundary=c6c7c7d11241dde5747f0a0c29d8e7069d0ee77b974969f31514bb7aeb57
Date: Fri, 27 Feb 2026 23:08:30 +0000 (UTC)
From: Hunter Williams <huntershealthhacks@mail.beehiiv.com>
Mime-Version: 1.0
Message-ID: <h52gZ3J6QdiZ_-TDlxfDGQ@geopod-ismtpd-7>
Subject: The MCAS Peptide Stack
Reply-To: Hunter's Health Hacks <hunter@zeroats.com>
Feedback-ID: 
 =?us-ascii?Q?9627113e-419e-44d0-8eb2-73c44c4b9171=3Anewsletter=3Afd41630e-e91f-?=
 =?us-ascii?Q?46d9-a274-b740dab756d2=3Ac8f61fda6a60803?=
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Afd41630e-e91f-46d9-a274-b740dab756d2+9c40d639-6e1d-429?=
 =?us-ascii?Q?2-a9d7-0e4cbbb5d5db+9627113e-419e-44d0-?=
 =?us-ascii?Q?8eb2-73c44c4b9171=40unsub=2Ebeehiiv=2Ecom=3E=2C?=
 =?us-ascii?Q?_=3Chttps=3A=2F=2Fhuntershealthhacks=2Ebeehiiv=2Ecom=2Funsubscribe=2FeyJ0eXAiOi?=
 =?us-ascii?Q?JKV1QiLCJhbGciOiJIUzI1NiJ9=2EeyJzdWJzY3Jp?=
 =?us-ascii?Q?YmVyX2lkIjoiOWM0MGQ2MzktNmUxZC00MjkyLWE?=
 =?us-ascii?Q?5ZDctMGU0Y2JiYjVkNWRiIiwicG9zdF9pZCI6Ij?=
 =?us-ascii?Q?k2MjcxMTNlLTQxOWUtNDRkMC04ZWIyLTczYzQ0Y?=
 =?us-ascii?Q?zRiOTE3MSIsImxhc3RfcmVzb3VyY2VfZ3VpZCI6?=
 =?us-ascii?Q?IlBvc3Q6OTYyNzExM2UtNDE5ZS00NGQwLThlYjI?=
 =?us-ascii?Q?tNzNjNDRjNGI5MTcxIn0=2EkSZ-s6dMfIBoATvUDf?=
 =?us-ascii?Q?-Xwx53=5F7TqrsYrDNXiHwXZxbY=3E?=
List-Unsubscribe-Post: List-Unsubscribe=One-Click
sId: fd41630e-e91f-46d9-a274-b740dab756d2
x-beehiiv-ids: 
 =?us-ascii?Q?{=22account=5Fname=22=3A=22https=3A=2F=2Fhuntershealthhacks=2Ebeehiiv=2Ecom=2F=22=2C=22cam?=
 =?us-ascii?Q?paign=5Fid=22=3A=229627113e-419e-44d0-8eb2-73c4?=
 =?us-ascii?Q?4c4b9171=22=2C=22category=22=3A=22newsletter=22=2C=22emai?=
 =?us-ascii?Q?l=5Fgenerated=5Fat=22=3A1772233701=2C=22user=5Fid=22=3A=22f?=
 =?us-ascii?Q?d41630e-e91f-46d9-a274-b740dab756d2=22}?=
x-beehiiv-type: newsletter
x-list-id: fd41630e-e91f-46d9-a274-b740dab756d2
x-list-owner: <mailto:hunter@zeroats.com>
x-newsletter: https://huntershealthhacks.beehiiv.com/p/the-mcas-peptide-stack
x-newsletter-id: https://huntershealthhacks.beehiiv.com/
x-newsletter-signup: https://huntershealthhacks.beehiiv.com/subscribe
X-SG-EID: 
 =?us-ascii?Q?u001=2EVXMDIXn2fa+g+ucKwQBvoezrRjNBBJCTk8wFXvlJ6yYhrh=2F+ACKq8ZWJV?=
 =?us-ascii?Q?EO7veNaW5xH8Vxdm+c2ArDGcERy+LYNhm9ne4Sq?=
 =?us-ascii?Q?Tp6ejN4zu8Hk2g94uVzEmD2MLKU=2FNJ8yLKF8DnF?=
 =?us-ascii?Q?qY16F96jw0F7uF2a+YN8MO0aHIv=2FMUaJxTMmflH?=
 =?us-ascii?Q?5cDJnkY6TcyujkDJeH1L+6r3DkvJ0CxDAGXGtmt?=
 =?us-ascii?Q?BNo7aOtvHqy4tXC4KK4C9Fr06q6Vga3lCp0AUMf?=
 =?us-ascii?Q?drjmz3aUF1qvut57XFlOOa22=2FQ=3D=3D?=
X-SG-ID: 
 =?us-ascii?Q?u001=2ESdBcvi+Evd=2FbQef8eZF3BpTL9BgbK5wfSJMJGMsmprD1ZcmFObA4po1bG?=
 =?us-ascii?Q?aUE6gycKXL3zQZhXuUQn9tChysOltgtXWrvjRjU?=
 =?us-ascii?Q?3+ZCrxpYwjQQ8wEAUUyYSoOKXPjV8WtTr2gFeHO?=
 =?us-ascii?Q?p=2Fb0207MRPXzN4utpXfZBNZmWpsi9eDwm4E3XYB?=
 =?us-ascii?Q?1U6g5MY1OU8AT2mj4Hob=2Fl+cvaA31Y85RFGDv7B?=
 =?us-ascii?Q?v3cNElaVVtDtwvGyoDfXzhe288ONepqEWgrRPvR?=
 =?us-ascii?Q?yke2ScVwOC6taaCmz64NP2+leMrP=2FnfgqWbBEsO?=
 =?us-ascii?Q?M56gMyW3AnsXrL=2FV8llbxBx7YEjTXO1IWBf3T7s?=
 =?us-ascii?Q?JqqeL=2FcbGvArMVM8tctxzk+Sri4F0wxjIUAtbCT?=
 =?us-ascii?Q?C1UB0vsIle2n4+Z?=
To: "tjphuhs@gmail.com" <tjphuhs@gmail.com>
X-Entity-ID: u001.gzTWOylKgaQyNgcScFpyNQ==

--c6c7c7d11241dde5747f0a0c29d8e7069d0ee77b974969f31514bb7aeb57
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=utf-8
Mime-Version: 1.0

Happy Friday!

I just released a brand new podcast on Spotify breaking down something that=
 has become one of the most common questions I get in the peptide world.

Mast Cell Activation Syndrome aka MCAS.

Peptides & Mast Cell Activation | What You Need to Know + How To Fix It: (h=
ttps://open.spotify.com/episode/4kMOv0WToaZ3KP0cMuvGHe?si=3Ds1_dS_pBSVm6eGo=
SUCPhcg)

If you=E2=80=99ve ever taken a peptide and suddenly experienced flushing, h=
ives, rapid heart rate, GI distress, anxiety, or just felt =E2=80=9Coff,=E2=
=80=9D this episode is for you.

In this podcast, I walk through what MCAS actually is, why certain people a=
re more prone to it, why traditional approaches often fall short, and the c=
omprehensive stack I=E2=80=99ve seen help the most people move in the right=
 direction.

And if you=E2=80=99re someone who feels like peptides work great for everyo=
ne except you, I think this episode is going to give you a structured roadm=
ap.

Let=E2=80=99s get into it.

=E2=80=9CFYI, Taylor and I will be going live for a Saturday Morning Coffee=
 Talk tomorrow at 10:00 AM EST. Bring your coffee and questions!=E2=80=9C =
=E2=80=94=20

View image: (https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down,forma=
t=3Dauto,onerror=3Dredirect,quality=3D80/uploads/asset/file/5936d5f8-b544-4=
866-88e5-c95c8118f494/hunter_and_taylor.png?t=3D1768599290)
Follow image link: (https://www.youtube.com/live/hgI5Mpc-xDQ?si=3DGZYdLYz9r=
GKJQm4k)
Caption: [https://www.youtube.com/live/hgI5Mpc-xDQ?si=3DGZYdLYz9rGKJQm4k](h=
ttps://www.youtube.com/live/hgI5Mpc-xDQ?si=3DGZYdLYz9rGKJQm4k)

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**Why MCAS Happens (And Why It=E2=80=99s Not Always Your Fault)**

MCAS is more of a pattern than it is a disease.

Mast cells are immune cells that release histamine, prostaglandins, leukotr=
ienes, tryptase, and cytokines. They=E2=80=99re supposed to defend you agai=
nst threats. In MCAS, they become hyper-reactive.

So why does that happen?

There are a few major drivers:

1. **Primary / genetic predisposition**

Some people have mast cell proliferation issues like mastocytosis or heredi=
tary alpha tryptasemia. This is real. Some people are genetically wired to =
be more reactive.

2. **Secondary immune dysregulation**

This is what I see most often in the peptide world. Chronic allergies. Auto=
immune issues. Mold exposure. Chronic infections. Gut permeability. Long-te=
rm nervous system dysregulation. These people have an immune system that is=
 already on edge. Then you introduce a peptide that stimulates immune signa=
ling, and boom!=20

3. **Environmental triggers**

Food sensitivities. Stress. Temperature changes. Medications. Infections. E=
nvironmental toxins.

4. **Nervous system overload**

Fight-or-flight dominance. Low HRV. High resting heart rate. Chronic sympat=
hetic overdrive. Mast cells are extremely sensitive to stress chemistry.

For many people, peptides expose upstream instability.

Traditional antihistamines can help acutely. Benadryl can blunt a reaction.=
 But blocking histamine does not fix the immune imbalance.

And that=E2=80=99s where I think peptides shine when used correctly.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**The MCAS Stack**

In the podcast, I walk through the comprehensive stack I=E2=80=99ve seen wo=
rk best.

Let=E2=80=99s highlight the main players.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**Low Dose Naltrexone (LDN)**

If I had to choose one foundational agent, this would be it.

LDN is a short-acting opioid receptor antagonist that paradoxically increas=
es endogenous endorphins. Those endorphins bind regulatory T-cell receptors=
 and reduce pro-inflammatory cytokine signaling.

It calms immune overactivity.

It modulates microglia.

It reduces inflammatory tone.

It can directly inhibit mast cells.

I personally take 3 mg nightly. Some people start at 0.5 mg and titrate slo=
wly to 3=E2=80=934.5 mg. It=E2=80=99s highly individualized.

For a lot of people with MCAS tendencies, this is the backbone.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**Thymosin Alpha-1 (TA-1)**

If LDN is baseline immune modulation, TA-1 is immune recalibration.

TA-1 is a thymic peptide that binds toll-like receptors on dendritic cells =
and promotes T-cell maturation. It helps rebalance Th1/Th2 responses.

A lot of MCAS patients have immune polarization issues. TA-1 can help bring=
 balance.

The typical dose is 1.5mg, 2=E2=80=933 times per week for 8=E2=80=9312 week=
s.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**Thymalin**

Think of Thymalin as a broader thymic environment peptide.

Where TA-1 is a stronger signal, Thymalin is more of a reset.

Clinical protocols have used 10 mg intramuscular daily for 10 days as a pul=
se.

For longevity purposes I often use 2 mg daily.

For severe immune dysregulation, higher pulse protocols can make sense.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**KPV**

This one is massively underrated.

KPV is a tripeptide derived from alpha-MSH. It inhibits NF-kB and MAPK infl=
ammatory signaling.

It reduces IL-1 beta and IL-8.

It supports gut barrier integrity.

It reduces intestinal inflammation.

If someone=E2=80=99s MCAS is gut-driven, this is huge.

Typical dosing is 250=E2=80=93500 mcg orally or 0.5=E2=80=931 mg subcutaneo=
us daily for 4=E2=80=938 weeks.

This is one of those peptides that quietly does a lot.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**VIP (Vasoactive Intestinal Peptide)**

VIP is powerful.

It regulates vascular tone.

It calms neuroinflammation.

It modulates cytokine production.

It increases cAMP signaling.

However, VIP can cause flushing in sensitive individuals because it can act=
ivate mast cells via MRGPRX2 in some cases.

So I typically introduce VIP later.

50 mcg intranasal per nostril 4 times daily.

Or 50 mcg injected once daily to start.

For people with nervous system overload, low HRV, fight-or-flight dominance=
, VIP can be transformative.

But it must be introduced cautiously.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**PEA (Palmitoylethanolamide)**

PEA is not a peptide, but it=E2=80=99s extremely important.

PEA directly stabilizes mast cells.

Reduces neuroinflammation.

Activates PPAR-alpha.

Reduces TNF-alpha, IL-1 beta, IL-6.

Common dosing is 600 mg twice daily for 4=E2=80=938 weeks.

Then 300=E2=80=93600 mg twice daily maintenance.

Ultra-micronized forms are best for absorption.

This is one of the cleanest mast cell stabilizers available.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**GLP-1 Receptor Agonists**

GLP-1 receptors are present on mast cells and immune cells.

In a case series of 47 refractory MCAS patients, 89 percent showed improvem=
ent with GLP-1 receptor agonists.

GLP-1 agonists:

* Reduce mast cell degranulation.

* Lower histamine and leukotriene release.

* Improve insulin sensitivity.

* Reduce systemic inflammation.

* Improve gut barrier stability.

* Lower CRP

For MCAS, I suggest 0.25 mg weekly or less.

You can even split into 0.125 mg twice weekly.

At low doses, you can get immune benefits without massive appetite suppress=
ion.

This is a very powerful addition for the right person.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**What to Expect**

This works in phases.

Weeks 1=E2=80=932:

* Gradual introduction.

* Assess tolerance.

Weeks 3=E2=80=936:

* Reduced flares.

* Improved gut stability.

* Less skin reactivity.

Weeks 6=E2=80=9312:

* Immune recalibration.

* More resilience to triggers.

* Less reliance on antihistamines.

Some people continue LDN and PEA long term.

=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94

**Final Thoughts**

Let me be clear,_ this peptide stack is not a cure-all!_

There are genetic cases.

There are mold-driven cases.

There are trauma-driven nervous system cases.

There are complex autoimmune cases.

No stack fixes everything.



But I have seen people go from reacting every single time they take CJC, Ip=
amorelin, or other peptides, to reacting only 1 out of 10 times.

If we can reduce frequency, reduce severity, improve quality of life, and r=
educe dependence on rescue medications, that=E2=80=99s a win in my book.

If this is something you struggle with, go listen to the full podcast on Sp=
otify. I break down mechanisms, dosing, sequencing, and nuance in detail.

I=E2=80=99m honored to get to do this work.

Thank you for being here.

Thank you for supporting.

And thank you for trusting me on your health journey!=20

Best,

Hunter Williams


=E2=80=94=E2=80=94=E2=80=94

You are reading a plain text version of this post. For the best experience,=
 copy and paste this link in your browser to view the post online:
https://huntershealthhacks.beehiiv.com/p/the-mcas-peptide-stack

--c6c7c7d11241dde5747f0a0c29d8e7069d0ee77b974969f31514bb7aeb57
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=utf-8
Mime-Version: 1.0

<!DOCTYPE html><html lang=3D"en" xmlns=3D"http://www.w3.org/1999/xhtml" xml=
ns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-microsoft-com=
:office:office" style=3D"font-size:16px;"><head></head><head><meta charset=
=3D"utf-8"/><!--[if !mso]><!--><meta http-equiv=3D"X-UA-Compatible" content=
=3D"IE=3Dedge"/><!--<![endif]--><meta name=3D"viewport" content=3D"width=3D=
device-width,initial-scale=3D1"/><meta name=3D"x-apple-disable-message-refo=
rmatting"/><meta name=3D"format-detection" content=3D"telephone=3Dno,addres=
s=3Dno,email=3Dno,date=3Dno,url=3Dno"/><meta name=3D"color-scheme" content=
=3D"light"/><meta name=3D"supported-color-schemes" content=3D"light"/><titl=
e>The MCAS Peptide Stack</title><!--[if mso]><xml><o:OfficeDocumentSettings=
><o:AllowPNG/><o:PixelsPerInch>96</o:PixelsPerInch></o:OfficeDocumentSettin=
gs></xml><![endif]--><style>
  :root { color-scheme: light; supported-color-schemes: light; }
  body { margin: 0; padding: 0; min-width: 100%!important; -ms-text-size-ad=
just: 100% !important; -webkit-transform: scale(1) !important; -webkit-text=
-size-adjust: 100% !important; -webkit-font-smoothing: antialiased !importa=
nt; }
  .body { word-wrap: normal; word-spacing:normal; }
  table.mso { width: 100%; border-collapse: collapse; padding: 0; table-lay=
out: fixed; }
  img { border: 0; outline: none; }
  table {  mso-table-lspace: 0px; mso-table-rspace: 0px; }
  td, a, span {  mso-line-height-rule: exactly; }
  #root [x-apple-data-detectors=3Dtrue],
  a[x-apple-data-detectors=3Dtrue],
  #MessageViewBody a { color: inherit !important; text-decoration: inherit =
!important; font-size: inherit !important; font-family: inherit !important;=
 font-weight: inherit !important; line-height: inherit !important; }
  span.MsoHyperlink { color: inherit !important; mso-style-priority: 99 !im=
portant; }
  span.MsoHyperlinkFollowed { color: inherit !important; mso-style-priority=
: 99 !important; }
  .a { background-color:#FFFFFF; }
  .b { background-color:#FFFFFF; }
  .c  { background-color:#FFFFFF; }
  .d { background-color:#EAEBEC; }
  .d2 { background-color:#FFFFFF; }
  .d3 { background-color:#FFFFFF; }
  h1 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h2 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h3 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h4 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h5 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h6 a { text-decoration:underline;color:#0C4A6E !important;font-style:ital=
ic; }
  h1, h1 a, h2, h2 a, h3, h3 a, h4, h4 a, h5, h5 a, h6, h6 a, ul, li, ol, p=
, p a { margin: 0;padding: 0; }
  h1 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:28px;color:#2A2A2A;line-height:1.75;padding-bottom:4px;p=
adding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  h2 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:24px;color:#2A2A2A;line-height:1.5;padding-bottom:4px;pa=
dding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  h3 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:20px;color:#2A2A2A;line-height:1.25;padding-bottom:4px;p=
adding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  h4 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:18px;color:#2A2A2A;line-height:1.125;padding-bottom:4px;=
padding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  h5 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:16px;color:#2A2A2A;line-height:1;padding-bottom:4px;padd=
ing-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  h6 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-we=
ight:400;font-size:14px;color:#2A2A2A;line-height:0.875;padding-bottom:4px;=
padding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }
  p { font-family:'Helvetica',Arial,sans-serif;font-weight:400;color:#2D2D2=
D;font-size:16px;line-height:1.5;padding-bottom:12px;padding-top:12px;mso-m=
argin-top-alt:12px;mso-margin-bottom-alt:12px; }
  p a, .e a, ul a, li a, .h a, .h2 a, .h3 a { word-break:break-word;color:#=
0C4A6E !important;text-decoration:underline;text-decoration-color:#0C4A6E;f=
ont-style:italic; }
  p a span, .e a span, ul a span, li a span { color: inherit }
  p .bold { font-weight:bold;color:#2D2D2D; }
  p span[style*=3D"font-size"] { line-height: 1.6; }
  .f p { font-size:12px;line-height:15px;color:#2D2D2D;padding:0; }
  .f p a { color:#2D2D2D !important; }
  .g p { font-family:'Helvetica',Arial,sans-serif;font-size:14px;line-heigh=
t:20px;font-weight:normal;margin:0; }
  .g p a  { text-decoration: underline; }
  .i p { font-family:'Helvetica',Arial,sans-serif;line-height:1.5;font-size=
:15px;color:#2D2D2D; }
  .i p a { color:#2D2D2D !important; }
  .i2 p { font-family:'Helvetica',Arial,sans-serif;line-height:1.5;font-siz=
e:15px;color:#2D2D2D; }
  .i2 p a { color:#2D2D2D !important; }
  .i3 p { font-family:'Helvetica',Arial,sans-serif;line-height:1.8;font-siz=
e:24px;color:#2D2D2D; }
  .i3 p a { color:#2D2D2D !important; }
  .h p a { color:#0C4A6E !important; }
  .h2 p a { color:#0C4A6E !important; }
  .h3 p a { color:#0C4A6E !important; }
  .f p a, .i p a, .i2 p a, .i3 p a, .h p a, .h2 p a, .h3 p a { text-decorat=
ion:underline; }
  .j { border-top:3px solid #030712; }
  .k p { padding-left:15px;padding-bottom:0px;padding-top:6px;mso-margin-to=
p-alt:6px;mso-margin-bottom-alt:0px;mso-margin-left-alt:15px; }
  .o { background-color:#FFFFFF;border:1px solid #F1F1F1;border-radius:5px;=
 }
  .o p { font-family:'Helvetica',Arial,sans-serif;padding:0px;margin:0px; }
  .l p,
  .l p a, .l a { font-size:14px;line-height:20px;font-weight: bold;color:#2=
D2D2D;padding-bottom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }
  .m p,
  .m p a { font-size:13px;line-height:18px;font-weight:400;color:#2D2D2D;pa=
dding-bottom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }
  .n p,
  .n p a { font-size:12px;line-height:17px;font-weight:400;color:#2D2D2D;pa=
dding-bottom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }
  .p { background-color:#FFFFFF;max-width:520px;border:1px solid #E1E8ED;bo=
rder:1px solid rgba(80, 80, 80, 0.3);border-radius:5px; }
  .q { font-size:16px;font-family:Helvetica,Roboto,Calibri,sans-serif !impo=
rtant;border:1px solid #e1e8ed;border:1px solid rgba(80, 80, 80, 0.3);borde=
r-radius:10px;background-color:#FFFFFF; }
  .q p { font-size:16px;font-family:system-ui,Helvetica,Roboto,Calibri,sans=
-serif !important;color:#222222;padding:4px 0; }
  .r { border:1px solid #E1E8ED !important;border-radius:5px; }
  .s p { font-size: 14px; line-height: 17px; font-weight: 400; color: #6978=
82; text-decoration: none; }
  .t p { font-family:'Helvetica',Arial,sans-serif;font-size:12px;line-heigh=
t:1.5;font-weight:400;color:#000000;font-style:italic;padding:0px; }
  .v { border-radius:10px;border:solid 0px #030712;background-color:#030712=
;font-family:'Verdana',Geneva,sans-serif;color:#FFFFFF; }
  .v a { text-decoration:none;display:block;color:#FFFFFF; }
  .w p { font-size:12px;line-height:15px;font-weight:400;color:#FFFFFF; }
  .w p a { text-decoration: underline !important;color:#FFFFFF !important; =
}
  ul { font-family:'Helvetica',Arial,sans-serif;margin:0px 0px 0px 25px !im=
portant;padding:0px !important;color:#2D2D2D;line-height:24px;list-style-ty=
pe:disc !important;font-size:16px; }
  ul ul { list-style-type:circle !important; }
  ul ul ul { list-style-type:square !important; }
  ul ul ul ul { list-style-type:disc !important; }
  ul ul ul ul ul { list-style-type:circle !important; }
  ul ul ul ul ul ul { list-style-type:square !important; }
  ul ul ul ul ul ul ul { list-style-type:disc !important; }
  ul ul ul ul ul ul ul ul { list-style-type:circle !important; }
  ul ul ul ul ul ul ul ul ul { list-style-type:square !important; }
  ul > li { font-family:'Helvetica',Arial,sans-serif;margin:10px 0px 0px 0p=
x !important;padding: 0px 0px 0px 0px !important; color: #2D2D2D; }
  ol { font-family:'Helvetica',Arial,sans-serif;margin: 0px 0px 0px 25px !i=
mportant;padding:0px !important;color:#2D2D2D;line-height:24px;list-style:d=
ecimal;font-size:16px; }
  ol > li { font-family:'Helvetica',Arial,sans-serif;margin:10px 0px 0px 0p=
x !important;padding: 0px 0px 0px 0px !important; color: #2D2D2D; }
  .e h3,
  .e p,
  .e span { padding-bottom:0px;padding-top:0px;mso-margin-top-alt:0px;mso-m=
argin-bottom-alt:0px; }
  .e span,
  .e li { font-family:'Helvetica',Arial,sans-serif;font-size:16px;color:#2D=
2D2D;line-height:24px; }
  .rec { font-family:  ui-sans-serif, system-ui, -apple-system, BlinkMacSys=
temFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-ser=
if, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol", "Noto Color E=
moji" !important; }
  .rec__button:hover { background-color: #f9fafb !important; }
  .copyright a {color: inherit !important; text-decoration: none !important=
; font-size: inherit !important; font-family: inherit !important; font-weig=
ht: inherit !important; line-height: inherit !important;}
  .txt_social p { padding: 0; word-break: break-all; }
  .table, .table-c, .table-h { border: 1px solid #C0C0C0; }
  .table-c { padding:5px; background-color:#FFFFFF; }
  .table-c p { color: #2D2D2D; font-family:'Helvetica',Arial,sans-serif !im=
portant;overflow-wrap: break-word; }
  .table-h { padding:5px; background-color:#F1F1F1; }
  .table-h p { color: #2A2A2A; font-family:'Trebuchet MS','Lucida Grande',T=
ahoma,sans-serif !important;overflow-wrap: break-word; }
  @media only screen and (max-width:667px) {
    .aa, .w100pc { width: 100% !important; }
    .bb img { width: 100% !important; height: auto !important; max-width: n=
one !important; }
    .cc { padding: 0px 8px !important; }
    .ee { padding-top:10px !important;padding-bottom:10px !important; }
    .ff ul, .ff ol { margin: 0px 0px 0px 10px !important;padding: 0px !impo=
rtant; }
    .ff li { margin:10px 0px 0px 10px !important; }
    .r {height:140px !important;}
    .s p { font-size:13px !important;line-height:15px !important; }
    .mob-hide {display:none !important;}
    .mob-show {display: block !important; width: auto !important; overflow:=
 visible !important; float: none !important; max-height: inherit !important=
; line-height: inherit !important;}
    .mob-stack {width:100% !important;display:block !important;}
    .mob-w-full {width:100% !important;}
    .mob-block {display:block !important;}
    .embed-img {padding:0px 0px 12px 0px !important;}
    .socialShare {padding-top:15px !important;}
    .rec { padding-left:15px!important;padding-right:15px!important; }
    .bodyWrapper { padding:10px 4px 10px 4px !important; }
    .social-mobile {float:left !important;margin-top:10px !important;}
  }
  @media screen and (max-width: 480px) {
    u + .a .gg { width: 100% !important; width: 100vw !important; }
    .tok-heart { padding-top:75% !important; }
    .tok-play { padding-top: 250px !important; }
  }
  @media screen and (max-width: 320px) {
    .tok-heart { padding-top:65% !important; }
  }
  .u { border: 1px solid #CACACA !important; border-radius: 2px !important;=
 background-color: #ffffff !important; padding: 0px 13px 0px 13px !importan=
t; font-family:ui-sans-serif,system-ui,-apple-system,BlinkMacSystemFont,"Se=
goe UI",Roboto,"Helvetica Neue",Arial,"Noto Sans",sans-serif !important;fon=
t-size: 12px !important; color: #767676 !important; }
  .u a { text-decoration: none; display: block !important; color: #767676 !=
important; margin: 0px !important; }
  .u span, .u img { color: #767676 !important;margin:0px !important; max-he=
ight:32px !important;background-color:#ffffff !important; }
</style><!--[if mso]><style type=3D"text/css">
    h1, h2, h3, h4, h5, h6 {font-family: Arial, sans-serif !important;}
    body, table, td, p, a, span {font-family: Arial, sans-serif !important;=
}
    sup { font-size: 100% !important;vertical-align: .5em !important;mso-te=
xt-raise: -1.5% !important;line-height: 0 !important; }
    ul { margin-left:0px !important; margin-right:10px !important; margin-t=
op:20px !important; margin-bottom:20px !important; }
    ul li { margin-left: 0px !important; mso-special-format: decimal; }
    ol { margin-left:0px !important; margin-right:10px !important; margin-t=
op:20px !important; margin-bottom:20px !important; }
    ol li { margin-left: 0px !important; mso-special-format: decimal; }
    li.listItem { margin-left:15px !important; margin-top:0px !important; }
    .paddingDesktop { padding: 10px 0 !important; }
    .edm_outlooklist { margin-left: -20px !important; }
    .embedImage { display:none !important; }
</style><![endif]--><!-- __merge_tags_in_links__ --><style></style></head><=
body class=3D"a" style=3D"margin:0px auto;padding:0px;word-wrap:normal;word=
-spacing:normal;background-color:#FFFFFF;"><div role=3D"article" aria-roled=
escription=3D"email" aria-label=3D"email_name" lang=3D"en" style=3D"font-si=
ze:1rem"><div style=3D"display:none;max-height:0px;overflow:hidden;"> New v=
ideo is live! &#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;=
&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#1=
60;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;=
&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#82=
04;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#820=
4;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#=
8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160=
;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#=
160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204=
;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;=
&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#1=
60;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;=
&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#82=
04;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#820=
4;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#=
8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160=
;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#=
160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204=
;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;=
&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#1=
60;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;=
&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#82=
04;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204; </div><tab=
le role=3D"none" width=3D"100%" border=3D"0" cellspacing=3D"0" align=3D"cen=
ter" cellpadding=3D"0" class=3D"gg"><tr><td align=3D"center" valign=3D"top"=
><table role=3D"none" width=3D"670" border=3D"0" cellspacing=3D"0" cellpadd=
ing=3D"0" class=3D"aa" style=3D"width:670px;table-layout:fixed;"><tr><td cl=
ass=3D"bodyWrapper" align=3D"center" valign=3D"top" style=3D"padding:10px 5=
px 10px 5px;"><table role=3D"none" width=3D"100%" border=3D"0" cellspacing=
=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=3D"center" valign=
=3D"top" style=3D"border-width:0px 0px 0px 0px;border-style: solid; border-=
color: #FFFFFF;border-radius:10px 10px 0px 0px;background-color:#FFFFFF;" c=
lass=3D"c"><table role=3D"none" width=3D"100%" border=3D"0" cellspacing=3D"=
0" cellpadding=3D"0" align=3D"center"><tr id=3D"header"><td style=3D"paddin=
g:15px 15px 0px 15px;"><div style=3D"padding-top:0px;padding-right:0px;padd=
ing-bottom:20px;padding-left:0px;"><table role=3D"none" width=3D"100%" bord=
er=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td class=
=3D"f" align=3D"right" valign=3D"top"><p> February 27, 2026 &nbsp; | &nbsp;=
 <a href=3D"https://link.mail.beehiiv.com/ss/c/u001.KRi0pFg1TnB-L5Xr4VTHbTU=
XhpH0c4aibrubwMtxLGEIUaSv5HtWd5ujPkVIrtS2V0iqQqhGD7cznaxXKgC4eMANodNAYSPhZj=
8EfKTtbco1ZDEYNg83rR3wuMABUktXE1Sp9TvLh2oZhiGHhx4WAXdFmc3mgwcrWO-gkMiq8-eTN=
wqXk_zmzl-RSAtOIdGDAQJe18uJ0xbcOPo2jrC5JFA1eNfnRxBWe17OZCjy8OLLtm0htcPFMc8t=
yPWs9sC_pBlKimi2Saq3W0LMr9t85YvdWUxodrI-ne0E9-xe04dQJCJvpMK6qqWXs7CJp9xw8qm=
nWRFNJm0ejcbx0nOD-a0fQcd4Gb5N0Nju0juCWkMEG9D4BAo3ItR_MRTnQ61fRVhSbG2JlHCITG=
EDgl8WjpgbvhQpe5NL7KF_mEHveUl10whOPlEJwZHDlVWDBk2HpyWnFSAXtfMd6w43Yd7ZsjgaY=
_5NnJ-23kiF05c7wZZU9hZsZ3dcCIZH7d7nAKHFFs2Ii2_zdZLg7BKdKmW1l50tac0FNgYXa2au=
3KP2xUch17xVXR-uwIhFqwwcwiOesapk46DGujHziSQRJ6fOMNX5zMbnfieij8aervKpwh4KizN=
8Selc2FtXU91qKnHPSArMlJx73lv4-lFlG1TETDn5WdKWG0Bugsh8ZixuWMmq9TOPuteTh_RVyn=
7qHzSTSriDF7RFyl13-herbqQ9hugTs9AIsWFiEmeYH-Tsjc25DOGf4aw7ZeAhCTP0v9zdwigF8=
H3rNK9bavj9OV_zeU3IsrpH5cdX9V3-1hW5j33RSS1pgjgp_HH88cLM6H1g_GhVnPYEvKOF8nL0=
wsaXJUp9F8wG--RS6CWT4SsGtmI/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h0/h001.gMHi0OzdNks0=
pMuXeM6FgGRajtsjZ1gOCRw_2o0iV9Q"><span class=3D"translation_missing" title=
=3D"translation missing: en.templates.posts.email.header.read_online">Read =
Online</span></a></p></td></tr><tr><td class=3D"dd" align=3D"center" valign=
=3D"top" style=3D"padding:15px 0;"><table role=3D"none" width=3D"100%" bord=
er=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=
=3D"center" valign=3D"top"><h1 style=3D"text-align:left;font-family:'Trebuc=
het MS','Lucida Grande',Tahoma,sans-serif;font-weight:Bold;font-size:32px;c=
olor:#2A2A2A;padding:2px 0;line-height:38px;"> The MCAS Peptide Stack </h1>=
<p style=3D"text-align:left;font-family:'Helvetica',Arial,sans-serif;font-w=
eight:normal;font-size:20px;color:#3E3E3E;padding:5px 0;line-height:24px;">=
 New video is live! </p></td></tr></table></td></tr><tr><td align=3D"center=
" valign=3D"top" class=3D"dd"><table role=3D"none" width=3D"100%" border=3D=
"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=3D"l=
eft" valign=3D"middle" class=3D"mob-stack"><table role=3D"none" border=3D"0=
" cellspacing=3D"0" cellpadding=3D"0" align=3D"right" class=3D"social-mobil=
e"><tr><td align=3D"left" valign=3D"middle"><table role=3D"none" border=3D"=
0" cellspacing=3D"0" cellpadding=3D"0" align=3D"left" style=3D"width:100%">=
<tr><td align=3D"center" valign=3D"middle"><a href=3D"https://link.mail.bee=
hiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5cjL79TPHyEoXwqojJYlBS_0ilGq6qzXd_VV8=
HBuHQrptKyLBFecuvU8TJ1gD1E_Il3f1vk6hHiqFGJCFabHYCSE4DUOvZjrw4jLFNKDunda42Yr=
uV-oiuRlnOONypAfy25kdx2w1WWd3g4ba_FaGSHcFdHUXccrlan7orjQtVsMAgNP5-znze-FgHw=
hd7-bBmUKgtgt0MqcconOqj3Ipwu4WXSuHb2eghxmHhMHZnM2fK18i3GIH-O2XqAtXaLyLKvR-o=
MGZ2HTXIkbJjUgIZS_xrtN3MNu6VHAAeheXvFmjUSn2Q5iZH0cyD1X3ZKCgIQXS2k6SEFcb-uKq=
SCSbsjWuNTe94QExX0yEkRp5cO8S/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h1/h001.c0POj2CLGnE=
tfqmtc0HaBaokqg9Ti8kpGNzxv5Yi2W4" style=3D"text-decoration:none; display:bl=
ock;"><table role=3D"none" border=3D"0" cellspacing=3D"0" cellpadding=3D"0"=
 align=3D"center"><tr><td align=3D"center" valign=3D"middle" style=3D"borde=
r: 1px solid #E5E7EB; border-radius: 100%; width: 18px; height: 18px; paddi=
ng: 8px;"><img style=3D"display:block; width:100%; height:100%; max-width:1=
8px; max-height:18px; object-fit: contain;" alt=3D"share on facebook" width=
=3D"18" border=3D"0" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Ds=
cale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/heade=
r/facebook.png"/></td></tr></table></a></td><td width=3D"8" style=3D"width:=
8px;">&nbsp;</td><td align=3D"center" valign=3D"middle"><a href=3D"https://=
link.mail.beehiiv.com/ss/c/u001.UjJbMIoVWSyy6fZtu6gv3xz1suV0qZIhBEwv_Qi_LWc=
KpZU5P3ZXtSX83cXE0UMoGkXWfSfNzy6f_SRdYFdqqA1H5F0FIF12_wnE3HUn-Jx0NA36T4QbFP=
bBobe5oQGc2t380mNdSca315grNwoTGtybVtFSgpo1tR6_xwT8fq2HqoQ0DEY6nq6lGz9-1Mf3J=
SPTMSkRw1k2ASDq5DHOQWsIE8vCG5vcDcpouBZ05zAN7XxoX9Jo5TJ5QNjwq3mNpXL9eF8qs306=
lCiX78LkbZzR2Xa2FSNmAf6WCn049Y0ydvj00KMZ2i5AuG2jtWceJSjCKzGLOT5cmPgeUudsK7s=
Vt4x5hJe4U6P8K7WikcOsHH41AhLw7LJvwOAYJT4m6S9QhG1OH2KMI8r_vwHrXk3pT_tFPs3_uy=
NyZgzoujk/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h2/h001.ewqrV8xIomdoswradQNyZzgLQHqsJD=
dA4fqXXpnT-fk" style=3D"text-decoration:none; display:block;"><table role=
=3D"none" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"=
><tr><td align=3D"center" valign=3D"middle" style=3D"border: 1px solid #E5E=
7EB; border-radius: 100%; width: 18px; height: 18px; padding: 8px;"><img st=
yle=3D"display:block; width:100%; height:100%; max-width:18px; max-height:1=
8px; object-fit: contain;" alt=3D"share on twitter" width=3D"18" height=3D"=
18" border=3D"0" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale=
-down,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/header/x.=
png"/></td></tr></table></a></td><td width=3D"8" style=3D"width:8px;">&nbsp=
;</td><td align=3D"center" valign=3D"middle"><a href=3D"https://link.mail.b=
eehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5ckqsEQXxy1v_4uKeAt_RbthiNPHfyXjVzQ=
m18hqDOQb8xDebo6GSquTNDXGe6ibPKlAEBpsFUGnl-RuB1N9w0iCu8Vu8RDkQUaw2i0omOCgoz=
DA3ArqtqtHR_sHOUOYjQ4BrqQTSBzOCbteYbw6TaR_U4xep7ZoRgpmc4umzo1RIG423Rozkkl02=
MJLmTTRXw5VNL_rmUQ3SFUIrYU-QNEoGmUKOnXXYDmX_iYOpx6Todnu-bP7gAyITmbQ-uMEBNuW=
ZijpmCb6NfbuI6kJXHXEV-bUtWOPks1aqEZ8EOGoI3Qs0anleifgO_gbsr17c3I8pQuvw3Uin_r=
VYqUidRnhszObOdkLWVSZov-AkkRQujz6XC4PCNrGRxRhur_q7jg/4oi/WhEM1KS9Sb6HUKtul8=
E7nQ/h3/h001.Cl42GZmvIs3tjN7ojq2JHocwUiAr-RBAALxqchM4L30" style=3D"text-dec=
oration:none; display:block;"><table role=3D"none" border=3D"0" cellspacing=
=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=3D"center" valign=
=3D"middle" style=3D"border: 1px solid #E5E7EB; border-radius: 100%; width:=
 18px; height: 18px; padding: 8px;"><img style=3D"display:block; width:100%=
; height:100%; max-width:18px; max-height:18px; object-fit: contain;" alt=
=3D"share on threads" width=3D"18" height=3D"18" border=3D"0" src=3D"https:=
//media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down,format=3Dauto,onerror=3D=
redirect,quality=3D80/static_assets/header/threads.png"/></td></tr></table>=
</a></td><td width=3D"8" style=3D"width:8px;">&nbsp;</td><td align=3D"cente=
r" valign=3D"middle"><a href=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6=
KhFr6V_IfF6b8t1O5cqLWyTPQA35UBCDAeDm2PWu31FN7unBuw2JgHciT5NNvyGvz1hIjqKFFsO=
FWKtxueac8EJfu4Unitfyzz8Z-5Qqscw9azu7KARAEh8q7VG_NXu0O_4-aNV8ytf_0pPIRm_eWP=
h3RR6gF9sYm0rKlSmc1_4WVt_ZZx1vgIImlnm9xelG7YyDXwnZ-IdMfMxVAzafqWdPfsX5qWffN=
cvq3Ngr_BmS2BtB2V2JNxFJ8K99I07gzmroKcRXmNfOk-53HFd0LnfPlBU-EBt41eJTt02BLKWv=
LQFHYfTTqpN4krdG909GMsDTChpAoJxd7wgScPW8jjLPthPjyFIkbInhC4fFFDgjVbexDUtVs_g=
R_TtPh/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h4/h001.S5ZXKbxes1Wjs7UPk47j9Mk2TM-dpBbZh=
-ULRxb46Lg" style=3D"text-decoration:none; display:block;"><table role=3D"n=
one" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr>=
<td align=3D"center" valign=3D"middle" style=3D"border: 1px solid #E5E7EB; =
border-radius: 100%; width: 18px; height: 18px; padding: 8px;"><img style=
=3D"display:block; width:100%; height:100%; max-width:18px; max-height:18px=
; object-fit: contain;" alt=3D"share on linkedin" width=3D"18" height=3D"18=
" border=3D"0" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-d=
own,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/header/link=
edin.png"/></td></tr></table></a></td></tr></table></td></tr></table></td><=
/tr></table></td></tr><tr><td style=3D"line-height:0;"><div data-open-track=
ing=3D"true"> <img src=3D"https://link.mail.beehiiv.com/ss/o/u001.U0NhyFVr9=
IdSaTRbqTkuyQ/4oi/WhEM1KS9Sb6HUKtul8E7nQ/ho.gif" alt=3D"" width=3D"1" heigh=
t=3D"1" border=3D"0" style=3D"height:1px !important;width:1px !important;bo=
rder-width:0 !important;margin-top:0 !important;margin-bottom:0 !important;=
margin-right:0 !important;margin-left:0 !important;padding-top:0 !important=
;padding-bottom:0 !important;padding-right:0 !important;padding-left:0 !imp=
ortant;"/> </div></td></tr></table></div></td></tr><tr id=3D"content-blocks=
"><td class=3D"email-card-body" align=3D"center" valign=3D"top" style=3D"pa=
dding-bottom:px;"><table role=3D"none" width=3D"100%" border=3D"0" cellspac=
ing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td class=3D"dd" align=3D"=
left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p =
style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Hap=
py Friday!</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D=
"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-l=
ine-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">I just released a=
 brand new podcast on Spotify breaking down something that has become one o=
f the most common questions I get in the peptide world.</span></p></td></tr=
><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:l=
eft;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span =
style=3D"font-size:1.5rem;">Mast Cell Activation Syndrome aka MCAS.</span><=
/p></td></tr><tr class=3D"embed-gen-img-r"><td align=3D"center" valign=3D"t=
op" style=3D"padding:12px 27px 12px 27px;" class=3D"dd"><table role=3D"none=
" width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"=
center"><tr><td align=3D"center" valign=3D"top" class=3D"o" style=3D"paddin=
g:12px 12px 12px 12px;;background-color:#FFFFFF;border-color:#F1F1F1;border=
-radius:5px 5px 5px 5px;border-width:1px 1px 1px 1px;"><!--[if !mso]><!--><=
div style=3D"display:none; float:left; overflow:hidden; width:0; max-height=
:0; line-height:0;" class=3D"mob-show"><table role=3D"none" border=3D"0" ce=
llspacing=3D"0" cellpadding=3D"0" align=3D"right" width=3D"100%"><tr><td al=
ign=3D"center" valign=3D"top"><a href=3D"https://link.mail.beehiiv.com/ss/c=
/u001.8z62hi1uQ3TM4taX1dDvAhGlRHE1KNDjz9M5L2SJTUmDoJoyli-PcmqUm1J_HdWZq2ST-=
YF_Qtzn4zOqgIbGC_wer42W0ZsvdXqtwTga20RU6cphRtJJHgWG_49fG3KU30nkZvTVquzaXGpp=
R-h7zs7cqiupD3F0qMG_srbjH-mjCxU8fArEQyEwZUk_hSKfUgisT4qqQXok0UiSqa8LPQB7Y_L=
hnzPfgJJ6mukBQ5xrwxWhLj6HkiwPPIAy8aK9EgXoW0xBupaceYyTQM7YW-NockiluVkID1_x5K=
6SyVDcFjHl25Xvd6DdYmRb9Wdi/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h5/h001.fl9Hno3CfdZC7=
SVBie0WIDIk-S4I2F5apS6cujSREnM" target=3D"_blank"><img src=3D"https://image=
-cdn-fa.spotifycdn.com/image/ab6772ab000016922fbff0d68007989e5609dccd" widt=
h=3D"100%" style=3D"height:auto;display:block;"/></a></td></tr><tr><td heig=
ht=3D"16" style=3D"font-size:16px;line-height:16px;">&nbsp;</td></tr></tabl=
e></div><!--<![endif]--><table role=3D"none" border=3D"0" cellspacing=3D"0"=
 cellpadding=3D"0" align=3D"right" width=3D"100%"><tr><td width=3D"57%" ali=
gn=3D"center" valign=3D"middle" class=3D"mob-stack"><table role=3D"none" wi=
dth=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"cent=
er"><tr><td align=3D"left" valign=3D"middle" class=3D"l"><p><a href=3D"http=
s://link.mail.beehiiv.com/ss/c/u001.8z62hi1uQ3TM4taX1dDvAhGlRHE1KNDjz9M5L2S=
JTUmDoJoyli-PcmqUm1J_HdWZq2ST-YF_Qtzn4zOqgIbGC_wer42W0ZsvdXqtwTga20RU6cphRt=
JJHgWG_49fG3KU30nkZvTVquzaXGppR-h7zs7cqiupD3F0qMG_srbjH-mjCxU8fArEQyEwZUk_h=
SKfUgisT4qqQXok0UiSqa8LPQB7Y_LhnzPfgJJ6mukBQ5xrwxWhLj6HkiwPPIAy8aK9JbxjWgyM=
9DcYuc6U80NUAb8b_QeeEZODWOMiQvRXtMiEF71zEnYDPE0zamSPZDOD/4oi/WhEM1KS9Sb6HUK=
tul8E7nQ/h6/h001.HdpQJ-sB20dDyjHszOkxkQjg8wJtxPjm48OPhjentQU" style=3D"text=
-decoration:none;font-style:normal;color:#2D2D2D !important;font-size:14px;=
line-height:20px;" target=3D"_blank"> Peptides & Mast Cell Activation | Wha=
t You Need to Know + How To Fix It <tr><td align=3D"left" valign=3D"top" cl=
ass=3D"m"><p style=3D"font-size:13px;line-height:19px;color:#2D2D2D;"> The =
Hunter Williams Podcast =C2=B7 Episode </p></td></tr><tr><td align=3D"left"=
 valign=3D"bottom" class=3D"n" style=3D"vertical-align:bottom;padding-top:1=
2px;"><p style=3D"word-break:break-word;">open.spotify.com/episode/4kMOv0WT=
oaZ3KP0cMuvGHe?si=3Ds1_dS_pBSVm6eGoSUCPhcg</p></td></tr></a></p></td></tr><=
/table></td><td width=3D"3%" style=3D"font-size:16px;line-height:16px;" cla=
ss=3D"mob-hide">&nbsp;</td><td width=3D"40%" align=3D"left" valign=3D"top" =
class=3D"mob-hide"><a href=3D"https://link.mail.beehiiv.com/ss/c/u001.8z62h=
i1uQ3TM4taX1dDvAhGlRHE1KNDjz9M5L2SJTUmDoJoyli-PcmqUm1J_HdWZq2ST-YF_Qtzn4zOq=
gIbGC_wer42W0ZsvdXqtwTga20RU6cphRtJJHgWG_49fG3KU30nkZvTVquzaXGppR-h7zs7cqiu=
pD3F0qMG_srbjH-mjCxU8fArEQyEwZUk_hSKfUgisT4qqQXok0UiSqa8LPQB7Y_LhnzPfgJJ6mu=
kBQ5xrwxWhLj6HkiwPPIAy8aK9mkwO8TR_53lBaCAhG8YW6HVea0BgOh4Tw_6lcXuGkkMz3yMqs=
a6nmso0wX_DKtMb/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h7/h001.mNxBiqHhDh68fDn1DsWH00MK=
TyMGWBxhkOIL9Kh9buw" target=3D"_blank"><img src=3D"https://image-cdn-fa.spo=
tifycdn.com/image/ab6772ab000016922fbff0d68007989e5609dccd" width=3D"232" s=
tyle=3D"height:auto;display:block;"/></a></td></tr></table></td></tr></tabl=
e></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;t=
ext-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.=
0%;"><span style=3D"font-size:1.5rem;">If you=E2=80=99ve ever taken a pepti=
de and suddenly experienced flushing, hives, rapid heart rate, GI distress,=
 anxiety, or just felt =E2=80=9Coff,=E2=80=9D this episode is for you.</spa=
n></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15=
px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:=
150.0%;"><span style=3D"font-size:1.5rem;">In this podcast, I walk through =
what MCAS actually is, why certain people are more prone to it, why traditi=
onal approaches often fall short, and the comprehensive stack I=E2=80=99ve =
seen help the most people move in the right direction.</span></p></td></tr>=
<tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:le=
ft;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span s=
tyle=3D"font-size:1.5rem;">And if you=E2=80=99re someone who feels like pep=
tides work great for everyone except you, I think this episode is going to =
give you a structured roadmap.</span></p></td></tr><tr><td class=3D"dd" ali=
gn=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word=
;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem=
;">Let=E2=80=99s get into it.</span></p></td></tr><tr><td align=3D"center" =
valign=3D"top" style=3D"padding:12px 19px 12px 19px;" class=3D"dd"><table r=
ole=3D"none" width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0=
" align=3D"center" class=3D"d" style=3D"background-color:#EAEBEC;border-col=
or:#030712;border-radius:10px 10px 10px 10px;border-style:solid;border-widt=
h:1px 1px 1px 1px;"><tr><td align=3D"center" valign=3D"top" style=3D"paddin=
g:19px 19px 19px 19px;" class=3D"dd"><table role=3D"none" width=3D"100%" bo=
rder=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td ali=
gn=3D"left" valign=3D"top" class=3D"i"><p style=3D"color:#2D2D2D;font-weigh=
t:normal;margin:0px;text-align:left;"><span style=3D"font-size:1.5rem;">FYI=
, Taylor and I will be going live for a Saturday Morning Coffee Talk tomorr=
ow at 10:00 AM EST. Bring your coffee and questions!</span></p></td></tr></=
table></td></tr></table></td></tr><tr><td align=3D"center" valign=3D"top" s=
tyle=3D"padding-bottom:20px;padding-left:15px;padding-right:15px;padding-to=
p:20px; " class=3D"dd"><table role=3D"none" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" style=3D"margin:0 auto 0 auto;"><tr><td align=3D"center" =
valign=3D"top" style=3D"width:630px;"><a href=3D"https://link.mail.beehiiv.=
com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5comncxa10e9Wiq_iGsXeqxzVf1b5BJ0rk9Z4NfcnK=
IU91oyHoltT5fKTi2RlzO3RT43SOWRNUyxkHhIR7xVrnLuPflGBeCp1vWe82QzLGFTLyjZ-eFW2=
oe5CklnBwSFSlVV6SiztFxUluPAGzOX_ZLunVUBcwchz_-AIUw4TzhGAA3-3TUDr05xM9QX7UGc=
axEaWIRmgwUKuGFC2pxmw7hKTHaBmH0rYjCRp8WC2B5us71r4y2G-2Kg3ZbGTG8RXYILm1DV7dY=
kXnSUKrN0jbgk/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h8/h001.oyly-nfj7grb1HqjtjkLZbVIqJ=
hKUjUkblA3SqQrryE" rel=3D"noopener noreferrer nofollow" style=3D"text-decor=
ation:none;" target=3D"_blank"><img src=3D"https://media.beehiiv.com/cdn-cg=
i/image/fit=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/uplo=
ads/asset/file/5936d5f8-b544-4866-88e5-c95c8118f494/hunter_and_taylor.png?t=
=3D1768599290" alt=3D"" height=3D"auto" width=3D"630" style=3D"display:bloc=
k;width:100%;" border=3D"0"/></a></td></tr><tr><td align=3D"center" valign=
=3D"top" class=3D"t" style=3D"width:630px; padding: 4px 0px 4px 0px;"><a hr=
ef=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5comncxa10=
e9Wiq_iGsXeqxzVf1b5BJ0rk9Z4NfcnKIU91oyHoltT5fKTi2RlzO3RT43SOWRNUyxkHhIR7xVr=
nLuPflGBeCp1vWe82QzLGFTLyjZ-eFW2oe5CklnBwSFSlVV6SiztFxUluPAGzOX_ZLunVUBcwch=
z_-AIUw4TzhGAA3-3TUDr05xM9QX7UGcaxI-VVkgp22v3dZ3pzSBmJDA2IkL2Ocqsha_R_sqjaK=
ZRvbLLUvOu1ZXeuWM9OXrvZJbSFs2T7oE0_ajnI4x1mek/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h9=
/h001.61CqO9zxWo3xx-kmIPOc2S1zznXMkMvEzcYMGSKgxv4" target=3D"_blank" rel=3D=
"noopener noreferrer nofollow" style=3D"text-decoration:underline;text-deco=
ration-color:#000000;"><p><a class=3D"link" href=3D"https://link.mail.beehi=
iv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5comncxa10e9Wiq_iGsXeqxzVf1b5BJ0rk9Z4Nf=
cnKIU91oyHoltT5fKTi2RlzO3RT43SOWRNUyxkHhIR7xVrnLuPflGBeCp1vWe82QzLGFTLyjZ-e=
FW2oe5CklnBwSFSlVV6SiztFxUluPAGzOX_ZLunVUBcwchz_-AIUw4TzhGAA3-3TUDr05xM9QX7=
UGcaxBP6WiiHEggvTqptQlzawa9BkzXpy4e6rt1B1rSFCNNcbCIJbViEErQSpv-htSlXshcHoP7=
M6mb6KsvdUMSNj3E/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h10/h001.QPbHlGlJ8yM8reOa5jcBj3=
lKFY6pfR7Ev9X-w1un0ic" target=3D"_blank" rel=3D"noopener noreferrer nofollo=
w"><span>https://www.youtube.com/live/hgI5Mpc-xDQ?si=3DGZYdLYz9rGKJQm4k</sp=
an></a></p></a></td></tr></table></td></tr><tr><td align=3D"center" valign=
=3D"top" style=3D"font-size:0px;line-height:0px;padding:30px 0px 30px;" cla=
ss=3D"dd"><table class=3D"j" role=3D"none" width=3D"50%" border=3D"0" cells=
pacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td> &nbsp; </td></tr><=
/table></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 1=
5px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt=
:150.0%;"><span style=3D"font-size:1.5rem;"><b>Why MCAS Happens (And Why It=
=E2=80=99s Not Always Your Fault)</b></span></p></td></tr><tr><td class=3D"=
dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:bre=
ak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size=
:1.5rem;">MCAS is more of a pattern than it is a disease.</span></p></td></=
tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align=
:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><spa=
n style=3D"font-size:1.5rem;">Mast cells are immune cells that release hist=
amine, prostaglandins, leukotrienes, tryptase, and cytokines. They=E2=80=99=
re supposed to defend you against threats. In MCAS, they become hyper-react=
ive.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddi=
ng:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-he=
ight-alt:150.0%;"><span style=3D"font-size:1.5rem;">So why does that happen=
?</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:=
0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-heigh=
t-alt:150.0%;"><span style=3D"font-size:1.5rem;">There are a few major driv=
ers:</span></p></td></tr><tr><td style=3D"padding-bottom:12px;padding-left:=
37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=3D"margi=
n-left:0px;" class=3D"edm_outlooklist"><ol start=3D"1" style=3D"list-style-=
type:decimal;margin:0px 0px;padding:0px 0px 0px 0px;"><li class=3D"listItem=
 ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left=
;word-break:break-word;"><span style=3D"font-size:1.5rem;"><b>Primary / gen=
etic predisposition</b></span></p><p style=3D"mso-line-height-alt:150.0%;pa=
dding:0px;text-align:left;word-break:break-word;"><span style=3D"font-size:=
1.5rem;">Some people have mast cell proliferation issues like mastocytosis =
or hereditary alpha tryptasemia. This is real. Some people are genetically =
wired to be more reactive.</span></p></li><li class=3D"listItem ultext"><p =
style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:=
break-word;"><span style=3D"font-size:1.5rem;"><b>Secondary immune dysregul=
ation</b></span></p><p style=3D"mso-line-height-alt:150.0%;padding:0px;text=
-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">This =
is what I see most often in the peptide world. Chronic allergies. Autoimmun=
e issues. Mold exposure. Chronic infections. Gut permeability. Long-term ne=
rvous system dysregulation. These people have an immune system that is alre=
ady on edge. Then you introduce a peptide that stimulates immune signaling,=
 and boom! </span></p></li><li class=3D"listItem ultext"><p style=3D"mso-li=
ne-height-alt:150.0%;padding:0px;text-align:left;word-break:break-word;"><s=
pan style=3D"font-size:1.5rem;"><b>Environmental triggers</b></span></p><p =
style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:=
break-word;"><span style=3D"font-size:1.5rem;">Food sensitivities. Stress. =
Temperature changes. Medications. Infections. Environmental toxins.</span><=
/p></li><li class=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0=
%;padding:0px;text-align:left;word-break:break-word;"><span style=3D"font-s=
ize:1.5rem;"><b>Nervous system overload</b></span></p><p style=3D"mso-line-=
height-alt:150.0%;padding:0px;text-align:left;word-break:break-word;"><span=
 style=3D"font-size:1.5rem;">Fight-or-flight dominance. Low HRV. High resti=
ng heart rate. Chronic sympathetic overdrive. Mast cells are extremely sens=
itive to stress chemistry.</span></p></li></ol></div></td></tr><tr><td clas=
s=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-brea=
k:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font=
-size:1.5rem;">For many people, peptides expose upstream instability.</span=
></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15p=
x;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:1=
50.0%;"><span style=3D"font-size:1.5rem;">Traditional antihistamines can he=
lp acutely. Benadryl can blunt a reaction. But blocking histamine does not =
fix the immune imbalance.</span></p></td></tr><tr><td class=3D"dd" align=3D=
"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p=
 style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">An=
d that=E2=80=99s where I think peptides shine when used correctly.</span></=
p></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"font-size:0px;=
line-height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=3D"j" rol=
e=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" a=
lign=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><td class=
=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break=
:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-=
size:1.5rem;"><b>The MCAS Stack</b></span></p></td></tr><tr><td class=3D"dd=
" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break=
-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1=
.5rem;">In the podcast, I walk through the comprehensive stack I=E2=80=99ve=
 seen work best.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" st=
yle=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D=
"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Let=E2=80=
=99s highlight the main players.</span></p></td></tr><tr><td align=3D"cente=
r" valign=3D"top" style=3D"font-size:0px;line-height:0px;padding:30px 0px 3=
0px;" class=3D"dd"><table class=3D"j" role=3D"none" width=3D"50%" border=3D=
"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td> &nbsp; </=
td></tr></table></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padd=
ing:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-h=
eight-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>Low Dose Naltrexone=
 (LDN)</b></span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D=
"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-l=
ine-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">If I had to choos=
e one foundational agent, this would be it.</span></p></td></tr><tr><td cla=
ss=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-bre=
ak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fon=
t-size:1.5rem;">LDN is a short-acting opioid receptor antagonist that parad=
oxically increases endogenous endorphins. Those endorphins bind regulatory =
T-cell receptors and reduce pro-inflammatory cytokine signaling.</span></p>=
</td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;tex=
t-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%=
;"><span style=3D"font-size:1.5rem;">It calms immune overactivity.</span></=
p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;t=
ext-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.=
0%;"><span style=3D"font-size:1.5rem;">It modulates microglia.</span></p></=
td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-=
align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"=
><span style=3D"font-size:1.5rem;">It reduces inflammatory tone.</span></p>=
</td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;tex=
t-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%=
;"><span style=3D"font-size:1.5rem;">It can directly inhibit mast cells.</s=
pan></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px =
15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-al=
t:150.0%;"><span style=3D"font-size:1.5rem;">I personally take 3 mg nightly=
. Some people start at 0.5 mg and titrate slowly to 3=E2=80=934.5 mg. It=E2=
=80=99s highly individualized.</span></p></td></tr><tr><td class=3D"dd" ali=
gn=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word=
;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem=
;">For a lot of people with MCAS tendencies, this is the backbone.</span></=
p></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"font-size:0px;=
line-height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=3D"j" rol=
e=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" a=
lign=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><td class=
=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break=
:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-=
size:1.5rem;"><b>Thymosin Alpha-1 (TA-1)</b></span></p></td></tr><tr><td cl=
ass=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-br=
eak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fo=
nt-size:1.5rem;">If LDN is baseline immune modulation, TA-1 is immune recal=
ibration.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"=
padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-li=
ne-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">TA-1 is a thymic p=
eptide that binds toll-like receptors on dendritic cells and promotes T-cel=
l maturation. It helps rebalance Th1/Th2 responses.</span></p></td></tr><tr=
><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;=
word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span styl=
e=3D"font-size:1.5rem;">A lot of MCAS patients have immune polarization iss=
ues. TA-1 can help bring balance.</span></p></td></tr><tr><td class=3D"dd" =
align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-w=
ord;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5=
rem;">The typical dose is 1.5mg, 2=E2=80=933 times per week for 8=E2=80=931=
2 weeks.</span></p></td></tr><tr><td align=3D"center" valign=3D"top" style=
=3D"font-size:0px;line-height:0px;padding:30px 0px 30px;" class=3D"dd"><tab=
le class=3D"j" role=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" c=
ellpadding=3D"0" align=3D"center"><tr><td> &nbsp; </td></tr></table></td></=
tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align=
:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><spa=
n style=3D"font-size:1.5rem;"><b>Thymalin</b></span></p></td></tr><tr><td c=
lass=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-b=
reak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"f=
ont-size:1.5rem;">Think of Thymalin as a broader thymic environment peptide=
.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:=
0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-heigh=
t-alt:150.0%;"><span style=3D"font-size:1.5rem;">Where TA-1 is a stronger s=
ignal, Thymalin is more of a reset.</span></p></td></tr><tr><td class=3D"dd=
" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break=
-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1=
.5rem;">Clinical protocols have used 10 mg intramuscular daily for 10 days =
as a pulse.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=
=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"ms=
o-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">For longevity =
purposes I often use 2 mg daily.</span></p></td></tr><tr><td class=3D"dd" a=
lign=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-wo=
rd;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5r=
em;">For severe immune dysregulation, higher pulse protocols can make sense=
.</span></p></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"font=
-size:0px;line-height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=
=3D"j" role=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpaddi=
ng=3D"0" align=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><=
td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo=
rd-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=
=3D"font-size:1.5rem;"><b>KPV</b></span></p></td></tr><tr><td class=3D"dd" =
align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-w=
ord;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5=
rem;">This one is massively underrated.</span></p></td></tr><tr><td class=
=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break=
:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-=
size:1.5rem;">KPV is a tripeptide derived from alpha-MSH. It inhibits NF-kB=
 and MAPK inflammatory signaling.</span></p></td></tr><tr><td class=3D"dd" =
align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-w=
ord;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5=
rem;">It reduces IL-1 beta and IL-8.</span></p></td></tr><tr><td class=3D"d=
d" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:brea=
k-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:=
1.5rem;">It supports gut barrier integrity.</span></p></td></tr><tr><td cla=
ss=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-bre=
ak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fon=
t-size:1.5rem;">It reduces intestinal inflammation.</span></p></td></tr><tr=
><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;=
word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span styl=
e=3D"font-size:1.5rem;">If someone=E2=80=99s MCAS is gut-driven, this is hu=
ge.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddin=
g:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-hei=
ght-alt:150.0%;"><span style=3D"font-size:1.5rem;">Typical dosing is 250=E2=
=80=93500 mcg orally or 0.5=E2=80=931 mg subcutaneous daily for 4=E2=80=938=
 weeks.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"pa=
dding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line=
-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">This is one of those=
 peptides that quietly does a lot.</span></p></td></tr><tr><td align=3D"cen=
ter" valign=3D"top" style=3D"font-size:0px;line-height:0px;padding:30px 0px=
 30px;" class=3D"dd"><table class=3D"j" role=3D"none" width=3D"50%" border=
=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td> &nbsp;=
 </td></tr></table></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"p=
adding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-lin=
e-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>VIP (Vasoactive =
Intestinal Peptide)</b></span></p></td></tr><tr><td class=3D"dd" align=3D"l=
eft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p s=
tyle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">VIP =
is powerful.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=
=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"ms=
o-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">It regulates v=
ascular tone.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=
=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"ms=
o-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">It calms neuro=
inflammation.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=
=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"ms=
o-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">It modulates c=
ytokine production.</span></p></td></tr><tr><td class=3D"dd" align=3D"left"=
 style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=
=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">It incre=
ases cAMP signaling.</span></p></td></tr><tr><td class=3D"dd" align=3D"left=
" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p styl=
e=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">However=
, VIP can cause flushing in sensitive individuals because it can activate m=
ast cells via MRGPRX2 in some cases.</span></p></td></tr><tr><td class=3D"d=
d" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:brea=
k-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:=
1.5rem;">So I typically introduce VIP later.</span></p></td></tr><tr><td cl=
ass=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-br=
eak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fo=
nt-size:1.5rem;">50 mcg intranasal per nostril 4 times daily.</span></p></t=
d></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-a=
lign:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;">=
<span style=3D"font-size:1.5rem;">Or 50 mcg injected once daily to start.</=
span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px=
 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-a=
lt:150.0%;"><span style=3D"font-size:1.5rem;">For people with nervous syste=
m overload, low HRV, fight-or-flight dominance, VIP can be transformative.<=
/span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0p=
x 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-=
alt:150.0%;"><span style=3D"font-size:1.5rem;">But it must be introduced ca=
utiously.</span></p></td></tr><tr><td align=3D"center" valign=3D"top" style=
=3D"font-size:0px;line-height:0px;padding:30px 0px 30px;" class=3D"dd"><tab=
le class=3D"j" role=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" c=
ellpadding=3D"0" align=3D"center"><tr><td> &nbsp; </td></tr></table></td></=
tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align=
:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><spa=
n style=3D"font-size:1.5rem;"><b>PEA (Palmitoylethanolamide)</b></span></p>=
</td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;tex=
t-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%=
;"><span style=3D"font-size:1.5rem;">PEA is not a peptide, but it=E2=80=99s=
 extremely important.</span></p></td></tr><tr><td class=3D"dd" align=3D"lef=
t" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p sty=
le=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">PEA di=
rectly stabilizes mast cells.</span></p></td></tr><tr><td class=3D"dd" alig=
n=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;=
"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;=
">Reduces neuroinflammation.</span></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
>Activates PPAR-alpha.</span></p></td></tr><tr><td class=3D"dd" align=3D"le=
ft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p st=
yle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Reduc=
es TNF-alpha, IL-1 beta, IL-6.</span></p></td></tr><tr><td class=3D"dd" ali=
gn=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word=
;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem=
;">Common dosing is 600 mg twice daily for 4=E2=80=938 weeks.</span></p></t=
d></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-a=
lign:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;">=
<span style=3D"font-size:1.5rem;">Then 300=E2=80=93600 mg twice daily maint=
enance.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"pa=
dding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line=
-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Ultra-micronized for=
ms are best for absorption.</span></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
>This is one of the cleanest mast cell stabilizers available.</span></p></t=
d></tr><tr><td align=3D"center" valign=3D"top" style=3D"font-size:0px;line-=
height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=3D"j" role=3D"=
none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=
=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><td class=3D"dd=
" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break=
-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1=
.5rem;"><b>GLP-1 Receptor Agonists</b></span></p></td></tr><tr><td class=3D=
"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:br=
eak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-siz=
e:1.5rem;">GLP-1 receptors are present on mast cells and immune cells.</spa=
n></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15=
px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:=
150.0%;"><span style=3D"font-size:1.5rem;">In a case series of 47 refractor=
y MCAS patients, 89 percent showed improvement with GLP-1 receptor agonists=
.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:=
0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-heigh=
t-alt:150.0%;"><span style=3D"font-size:1.5rem;">GLP-1 agonists:</span></p>=
</td></tr><tr><td style=3D"padding-bottom:12px;padding-left:37px;padding-ri=
ght:27px;padding-top:12px;" class=3D"ee"><div style=3D"margin-left:0px;" cl=
ass=3D"edm_outlooklist"><ul style=3D"font-weight:normal;list-style-type:dis=
c;margin-bottom:12px !important;margin-top:12px !important;padding:0px 0px =
0px 0px;"><li class=3D"listItem ultext"><p style=3D"mso-line-height-alt:150=
.0%;padding:0px;text-align:left;word-break:break-word;"><span style=3D"font=
-size:1.5rem;">Reduce mast cell degranulation.</span></p></li><li class=3D"=
listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-al=
ign:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">Lower hi=
stamine and leukotriene release.</span></p></li><li class=3D"listItem ultex=
t"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-=
break:break-word;"><span style=3D"font-size:1.5rem;">Improve insulin sensit=
ivity.</span></p></li><li class=3D"listItem ultext"><p style=3D"mso-line-he=
ight-alt:150.0%;padding:0px;text-align:left;word-break:break-word;"><span s=
tyle=3D"font-size:1.5rem;">Reduce systemic inflammation.</span></p></li><li=
 class=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0=
px;text-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;=
">Improve gut barrier stability.</span></p></li><li class=3D"listItem ultex=
t"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-=
break:break-word;"><span style=3D"font-size:1.5rem;">Lower CRP</span></p></=
li></ul></div></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddin=
g:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-hei=
ght-alt:150.0%;"><span style=3D"font-size:1.5rem;">For MCAS, I suggest 0.25=
 mg weekly or less.</span></p></td></tr><tr><td class=3D"dd" align=3D"left"=
 style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=
=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">You can =
even split into 0.125 mg twice weekly.</span></p></td></tr><tr><td class=3D=
"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:br=
eak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-siz=
e:1.5rem;">At low doses, you can get immune benefits without massive appeti=
te suppression.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" sty=
le=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"=
mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">This is a ve=
ry powerful addition for the right person.</span></p></td></tr><tr><td alig=
n=3D"center" valign=3D"top" style=3D"font-size:0px;line-height:0px;padding:=
30px 0px 30px;" class=3D"dd"><table class=3D"j" role=3D"none" width=3D"50%"=
 border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td>=
 &nbsp; </td></tr></table></td></tr><tr><td class=3D"dd" align=3D"left" sty=
le=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"=
mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>What to E=
xpect</b></span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"=
padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-li=
ne-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">This works in phas=
es.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddin=
g:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-hei=
ght-alt:150.0%;"><span style=3D"font-size:1.5rem;">Weeks 1=E2=80=932:</span=
></p></td></tr><tr><td style=3D"padding-bottom:12px;padding-left:37px;paddi=
ng-right:27px;padding-top:12px;" class=3D"ee"><div style=3D"margin-left:0px=
;" class=3D"edm_outlooklist"><ul style=3D"font-weight:normal;list-style-typ=
e:disc;margin-bottom:12px !important;margin-top:12px !important;padding:0px=
 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D"mso-line-height-al=
t:150.0%;padding:0px;text-align:left;word-break:break-word;"><span style=3D=
"font-size:1.5rem;">Gradual introduction.</span></p></li><li class=3D"listI=
tem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:l=
eft;word-break:break-word;"><span style=3D"font-size:1.5rem;">Assess tolera=
nce.</span></p></li></ul></div></td></tr><tr><td class=3D"dd" align=3D"left=
" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p styl=
e=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Weeks 3=
=E2=80=936:</span></p></td></tr><tr><td style=3D"padding-bottom:12px;paddin=
g-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=
=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:no=
rmal;list-style-type:disc;margin-bottom:12px !important;margin-top:12px !im=
portant;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D=
"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-wo=
rd;"><span style=3D"font-size:1.5rem;">Reduced flares.</span></p></li><li c=
lass=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px=
;text-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">=
Improved gut stability.</span></p></li><li class=3D"listItem ultext"><p sty=
le=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:bre=
ak-word;"><span style=3D"font-size:1.5rem;">Less skin reactivity.</span></p=
></li></ul></div></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"pad=
ding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-=
height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Weeks 6=E2=80=9312:</=
span></p></td></tr><tr><td style=3D"padding-bottom:12px;padding-left:37px;p=
adding-right:27px;padding-top:12px;" class=3D"ee"><div style=3D"margin-left=
:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:normal;list-style=
-type:disc;margin-bottom:12px !important;margin-top:12px !important;padding=
:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D"mso-line-heigh=
t-alt:150.0%;padding:0px;text-align:left;word-break:break-word;"><span styl=
e=3D"font-size:1.5rem;">Immune recalibration.</span></p></li><li class=3D"l=
istItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-ali=
gn:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">More resi=
lience to triggers.</span></p></li><li class=3D"listItem ultext"><p style=
=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break=
-word;"><span style=3D"font-size:1.5rem;">Less reliance on antihistamines.<=
/span></p></li></ul></div></td></tr><tr><td class=3D"dd" align=3D"left" sty=
le=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"=
mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Some people =
continue LDN and PEA long term.</span></p></td></tr><tr><td align=3D"center=
" valign=3D"top" style=3D"font-size:0px;line-height:0px;padding:30px 0px 30=
px;" class=3D"dd"><table class=3D"j" role=3D"none" width=3D"50%" border=3D"=
0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td> &nbsp; </t=
d></tr></table></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddi=
ng:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-he=
ight-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>Final Thoughts</b></=
span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px=
 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-a=
lt:150.0%;"><span style=3D"font-size:1.5rem;">Let me be clear,</span><span =
style=3D"font-size:1.5rem;"><i> this peptide stack is not a cure-all!</i></=
span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px=
 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-a=
lt:150.0%;"><span style=3D"font-size:1.5rem;">There are genetic cases.</spa=
n></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15=
px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:=
150.0%;"><span style=3D"font-size:1.5rem;">There are mold-driven cases.</sp=
an></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 1=
5px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt=
:150.0%;"><span style=3D"font-size:1.5rem;">There are trauma-driven nervous=
 system cases.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" styl=
e=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"m=
so-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">There are com=
plex autoimmune cases.</span></p></td></tr><tr><td class=3D"dd" align=3D"le=
ft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p st=
yle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">No st=
ack fixes everything.</span></p></td></tr><tr><td class=3D"dd" align=3D"lef=
t" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p sty=
le=3D"mso-line-height-alt:150.0%;"></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
>But I have seen people go from reacting every single time they take CJC, I=
pamorelin, or other peptides, to reacting only 1 out of 10 times.</span></p=
></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;te=
xt-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0=
%;"><span style=3D"font-size:1.5rem;">If we can reduce frequency, reduce se=
verity, improve quality of life, and reduce dependence on rescue medication=
s, that=E2=80=99s a win in my book.</span></p></td></tr><tr><td class=3D"dd=
" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break=
-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1=
.5rem;">If this is something you struggle with, go listen to the full podca=
st on Spotify. I break down mechanisms, dosing, sequencing, and nuance in d=
etail.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"pad=
ding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-=
height-alt:150.0%;"><span style=3D"font-size:1.5rem;">I=E2=80=99m honored t=
o get to do this work.</span></p></td></tr><tr><td class=3D"dd" align=3D"le=
ft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p st=
yle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Thank=
 you for being here.</span></p></td></tr><tr><td class=3D"dd" align=3D"left=
" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p styl=
e=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Thank y=
ou for supporting.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" =
style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p style=
=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">And than=
k you for trusting me on your health journey! </span></p></td></tr><tr><td =
class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-=
break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"=
font-size:1.5rem;">Best,</span></p></td></tr><tr><td class=3D"dd" align=3D"=
left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p =
style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">Hun=
ter Williams</span></p></td></tr></table></td></tr></table></td></tr><tr><t=
d align=3D"center" valign=3D"top"><table role=3D"none" width=3D"100%" borde=
r=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td><tr><t=
d class=3D"b" align=3D"center" valign=3D"top" bgcolor=3D"#FFFFFF" style=3D"=
padding:0px 0px 0px 0px;border-style:solid;border-width: 0px 0px 0px 0px;bo=
rder-color: #FFFFFF;border-bottom-left-radius:10px;border-bottom-right-radi=
us:10px;"><table role=3D"none" width=3D"100%" border=3D"0" cellspacing=3D"0=
" cellpadding=3D"0" align=3D"center"><tr><td align=3D"center" valign=3D"top=
" bgcolor=3D"#030712" style=3D"padding:12px"><table role=3D"none" width=3D"=
100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr=
><td><span style=3D"padding-left:1px;"></span></td><td align=3D"center" val=
ign=3D"middle" width=3D"75" style=3D"width:75px;"><a href=3D"https://link.m=
ail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5cpS-F_LEoSVTRrCUpA6pXx4ySowSa=
6JTAs8MOcWTKfMGnJ7H6nQn_4bTKXjZpXbuJrYyf8rKs0C7W8dTTWCCUqc73wYXaosRIGsrfaPl=
m80gtqEoXG7wQOhVTS2PrVorwjgO-40hOamrsLa75V9hPsJlilqiibfXUhQCKOIegOXWCtLNkzv=
i8kvopMnyA7yGUzS4H-JG4uHXr3sIV_cOwGcPR4lyEkfOpD8y-Ef95S9YLnlrP7CCjAGoTMKMOe=
yZ9g/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h11/h001.dk-5hahJSnMWHqvR2fbYYLTRLRgRRu35Wl=
N5lmPOGGc" style=3D"text-decoration:none;"><img width=3D"22" height=3D"22" =
alt=3D"ig" border=3D"0" style=3D"display:block;max-width:22px;color:light" =
src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down,format=3Dau=
to,onerror=3Dredirect,quality=3D80/static_assets/instagram_light.png"/></a>=
</td><td align=3D"center" valign=3D"middle" width=3D"75" style=3D"width:75p=
x;"><a href=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5=
cgMEpWD5ybYd0PtdobGVPQx6ICwjIDkxekcU8YcQSpX7HKPLYVhwGNMzDO2adZut_RKG6wtWBpY=
ei4MonmzHS-S-_v7zSjEwLHxPgOFP8CFHqog7reBxSMJ08Mt-fDYOhnY6vQr988VDr7OORthiXH=
ft4pVk9YQ_WwUqwE9PjdKVCigQLZJj-J3t16yPK3Aq6LhnDo27HOUJ7hq4REhmh_OSWHkBi30nM=
ktqIuY_1Hlg-CtBvQmwmKPVU5I6f84gDA/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h12/h001.1_R5y=
BNDakxwPPCCIaIcaMCnJuRMek27FYIWT2WJk8M" style=3D"text-decoration:none;"><im=
g width=3D"22" height=3D"16" alt=3D"yt" border=3D"0" style=3D"display:block=
;max-width:22px;color:light" src=3D"https://media.beehiiv.com/cdn-cgi/image=
/fit=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/static_asse=
ts/youtube_light.png"/></a></td><td><span style=3D"padding-left:1px;"></spa=
n></td></tr></table></td></tr><tr><td align=3D"center" valign=3D"top" style=
=3D"padding-bottom:20px;padding-left:15px;padding-right:15px;padding-top:20=
px; " class=3D"dd"><table role=3D"none" border=3D"0" cellspacing=3D"0" cell=
padding=3D"0" style=3D"margin:0 auto 0 auto;"><tr><td align=3D"center" vali=
gn=3D"top" style=3D"width:189px;"><img src=3D"https://media.beehiiv.com/cdn=
-cgi/image/fit=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/u=
ploads/asset/file/77285135-fcd3-48e6-afed-97045dbefd05/beehiiv_profile_phot=
o_large.png?t=3D1744125569" alt=3D"" height=3D"auto" width=3D"189" style=3D=
"display:block;width:100%;border-radius:0px 0px 0px 0px;border-style:solid;=
border-width:0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" b=
order=3D"0"/></td></tr></table></td></tr><tr><td id=3D"want-more-heres-how-=
you-can-work-wi" class=3D"dd" align=3D"center" valign=3D"top" style=3D"colo=
r:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:center;"><h2 style=
=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:150.0%;"><span sty=
le=3D"font-size:1.5rem;">Want more? Here=E2=80=99s how you can work with me=
:</span></h2></td></tr><tr><td id=3D"join-my-private-coaching-group-the-" c=
lass=3D"dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weigh=
t:normal;padding:0px 15px;text-align:left;"><h4 style=3D"color:#2A2A2A;font=
-weight:normal;mso-line-height-alt:112.5%;"><span style=3D"font-size:1.5rem=
;">=F0=9F=91=89Join my private coaching group, The AXION Collective:</span>=
</h4></td></tr><tr><td style=3D"padding-bottom:12px;padding-left:37px;paddi=
ng-right:27px;padding-top:12px;" class=3D"ee"><div style=3D"margin-left:0px=
;" class=3D"edm_outlooklist"><ul style=3D"font-weight:normal;list-style-typ=
e:disc;margin-bottom:12px !important;margin-top:12px !important;padding:0px=
 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D"mso-line-height-al=
t:150.0%;padding:0px;text-align:left;word-break:break-word;"><span style=3D=
"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com=
/ss/c/u001.UjJbMIoVWSyy6fZtu6gv3xnGcH8KVDTA4C71EJ0NMLLrZUNxWPxdE_i0Q1M4vkRb=
ZlcTaMqLKuHYLNKXtPr_OYi7FUv9uokYVRuNd8G-XtutP72G_rJP9aMjMvzQ62Ny8D5gFXywCfh=
R6_t6VAqqHI4kKRJpnmwQxRGrua4qQC2faviPh1CCLwEoB3ntNPhb1IzGN_91v5s2Fmro6RoTFb=
pRYjMF3lffiBivbGHZZsn3XHr6prpOUcnUN_vkR0pPEO5pJ6cDcUncAZNQk2jtVA/4oi/WhEM1K=
S9Sb6HUKtul8E7nQ/h13/h001.TnRuvBmlTZ9niZflW1SlH7UJS9Gyf1DXEgBosZJ7mSs" targ=
et=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>The AXION Collecti=
ve</span></a></span></p></li></ul></div></td></tr><tr><td id=3D"try-zeroats=
-the-worlds-first-sugarf" class=3D"dd" align=3D"left" valign=3D"top" style=
=3D"color:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h4=
 style=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:112.5%;"><sp=
an style=3D"font-size:1.5rem;">=F0=9F=91=89Try Zeroats, the world=E2=80=99s=
 first sugar-free, naturally flavored oatmeal:</span></h4></td></tr><tr><td=
 style=3D"padding-bottom:12px;padding-left:37px;padding-right:27px;padding-=
top:12px;" class=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outloo=
klist"><ul style=3D"font-weight:normal;list-style-type:disc;margin-bottom:1=
2px !important;margin-top:12px !important;padding:0px 0px 0px 0px;"><li cla=
ss=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;t=
ext-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">St=
ore:=C2=A0</span><span style=3D"font-size:1.5rem;"><a class=3D"link" href=
=3D"https://link.mail.beehiiv.com/ss/c/u001.1w9CaH2HuNy0TNq9Sy-zLNDOfGm_GBS=
hiKqqb5ThPjswlSnCE_TfPRB6P1P0axL4KDjmLj4I4liBakZERkY1lJs0EQJ4dUSFSHtZhQdD4l=
2aOo4mKhqADiCmvb_E2qy2myoSCOJGn-Ib-M-nBL7JdPuI0wBL6sCCN7GuF-XTBVcaY2QgO1xVW=
BRe9gUUyQ3Pc9ohfXTLQfPLVyGSe8278nlUBaNYochoqiaNb6M025s/4oi/WhEM1KS9Sb6HUKtu=
l8E7nQ/h14/h001.XlO5GooENF2DSzyNdXx-e9pWAfOkp3DWHhvQ5v1JZz0" target=3D"_bla=
nk" rel=3D"noopener noreferrer nofollow"><span>https://zeroats.com/</span><=
/a></span><span style=3D"font-size:1.5rem;">=C2=A0</span></p></li><li class=
=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;tex=
t-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">Amaz=
on:=C2=A0</span><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D=
"https://link.mail.beehiiv.com/ss/c/u001.nUelgRZhw0fncfhI-zrahlyK1_iW4gORuh=
_iEcvZviWy4LPI_HFehbXWAhgtA7yP21qnvM-yahiCI-vNqgLUF8I1PHM1ci2b0lG_JD5dcs9g-=
h5A4P9muo_C7hhYezVZELDP5-iKag7zenqnmoWYG106qpgsUdsplVEjeA_QufjhvVp6YuMle2zM=
BaXdQ_noegK1o73nWN5yxR-MXCN1F68tToQCs16PN7y7NwJIh1E5FVk1-ta0rg36huqYuRE2/4o=
i/WhEM1KS9Sb6HUKtul8E7nQ/h15/h001.ToD919-9VCGnunEHAqyWhY_vFHOvTKRGJf9ytonZv=
Zg" target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>https://a.=
co/d/2gq1zJ9</span></a></span></p></li></ul></div></td></tr><tr><td id=3D"l=
ink-to-all-my-old-videos" class=3D"dd" align=3D"left" valign=3D"top" style=
=3D"color:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h4=
 style=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:112.5%;"><sp=
an style=3D"font-size:1.5rem;">=F0=9F=91=89</span><span style=3D"font-size:=
1.5rem;">Link To All My Old Videos:</span></h4></td></tr><tr><td style=3D"p=
adding-bottom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" =
class=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul =
style=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !import=
ant;margin-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listI=
tem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:l=
eft;word-break:break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"l=
ink" href=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5cp=
CIVGKzm6uRDaXwtdwgYlHeFoNB-B3n__5ACLgTG3E6KcLksYw0Un1JlpgXK6sbxksXD5Lm38nXG=
HwRj4UCUrkAXRY6sMpQM4V1pacLCTLqu80JscPwtm2hU1db2Uix2-QipMQojuAR-EEsf1sd0Cgd=
WiixLPEZEPu1R8uB4-JT0XhrZ1S9s0b-YyjzVGAL5M49onSHO021nyBmQ5HGqbCKyFt-6g3JbAg=
uA1fCsygnTOlRzvMMSPs_f_5IVNmmZmfhKI59zdVax-_gHapKauk2jxFwTBdfQe5MzEIHvI5pr6=
VzOgnnsHNnmgqcpuL89Kb3yZofvxX9sKs1_EdBPG0o1_9bP6imhXcpYn2JQuIF/4oi/WhEM1KS9=
Sb6HUKtul8E7nQ/h16/h001.n6EYoEa2oUp7uf38seOmUwY8PjzJN11NeCg2_oA5B4M" target=
=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>DropBox with all vid=
eos</span></a></span></p></li></ul></div></td></tr><tr><td id=3D"link-to-al=
l-my-old-videos" class=3D"dd" align=3D"left" valign=3D"top" style=3D"color:=
#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h4 style=3D"=
color:#2A2A2A;font-weight:normal;mso-line-height-alt:112.5%;"><span style=
=3D"font-size:1.5rem;">=F0=9F=91=89</span><span style=3D"font-size:1.5rem;"=
>Audio Versions of All Videos:</span></h4></td></tr><tr><td style=3D"paddin=
g-bottom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" class=
=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=
=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !important;m=
argin-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listItem u=
ltext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;w=
ord-break:break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"link" =
href=3D"https://link.mail.beehiiv.com/ss/c/u001.JrjGzO4qfF9nLlI-eIWxpH2-I2Z=
EOEuXtBWjQDV-sgcA7X3JGLaUVL20hBauq3RgWRfuIzpuU9XVdl4g6hFznZo9ikUcyIs088uEw3=
Cqmjm3RfhxpFcJ4yvrROtCRmtK2krkjFWkBJIUEGGVcrRPKZZjOOqgom8yF6KKwtpgS50SKiNRU=
U75Koh-7BOSwROstLLS1eQcrXdwEC-nb8LTen4IhEXBHrsmalhUUSbOSAuzvhvqJeLDH_XfGhn_=
bIzfuBsUlGyBFysJu26bfBQs8UXvoSFJsZWvaT_ysbnxfQv7fgHyOJDUmwiHhzq6Fzwj/4oi/Wh=
EM1KS9Sb6HUKtul8E7nQ/h17/h001.qoLQsV3H5kpN_9MYQfTdkzQ0BHmxXPoahmVcuXKFa1A" =
target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>Itunes</span><=
/a></span></p></li><li class=3D"listItem ultext"><p style=3D"mso-line-heigh=
t-alt:150.0%;padding:0px;text-align:left;word-break:break-word;"><span styl=
e=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv=
.com/ss/c/u001.8z62hi1uQ3TM4taX1dDvAhGlRHE1KNDjz9M5L2SJTUnkaMu-CnLUWB8qTtxW=
tSauEKVcsyFFaB9hkwstM9jnT9xoB9n5h7zwpOJ18e8_0Mvzpom4CS6tAHcJXY9TqGn8YtiaqOh=
oKzg-Gn-Kc912pdaUvdZv3v5yy6tTE1ormGuwA6p8LKXtpRZWXKIiy1ue3KOdvA2BaSD8biCnBB=
GCk_FntXNipTdyeHZje64hiwF4IuDJKYxnjaknPE2lBlXNQNfVGnXv5tHIc9-UaBqyfQ/4oi/Wh=
EM1KS9Sb6HUKtul8E7nQ/h18/h001.sdpJM_xCtNkiW73RW_W9DaEMMYTGzt2TjgFUgo_7X0c" =
target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>Spotify</span>=
</a></span></p></li></ul></div></td></tr><tr><td id=3D"get-the-peptide-chea=
t-sheet" class=3D"dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;=
font-weight:normal;padding:0px 15px;text-align:left;"><h3 style=3D"color:#2=
A2A2A;font-weight:normal;mso-line-height-alt:125.0%;"><span style=3D"font-s=
ize:1.5rem;">=F0=9F=91=89Get the Peptide Cheat Sheet:</span></h3></td></tr>=
<tr><td style=3D"padding-bottom:12px;padding-left:37px;padding-right:27px;p=
adding-top:12px;" class=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm=
_outlooklist"><ul style=3D"font-weight:normal;list-style-type:disc;margin-b=
ottom:12px !important;margin-top:12px !important;padding:0px 0px 0px 0px;">=
<li class=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;paddin=
g:0px;text-align:left;word-break:break-word;"><span style=3D"font-size:1.5r=
em;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com/ss/c/u001.97tz=
9iG2Fyt4lvKCE-s7rrZq_ShObZ8nl_CpGJXtrivCskgx5wO0iJI40ZvpP9ivR_nwfmiV4e-JFhe=
Eswy1hXRXm8DuKSOO_zOdPXwgThHqaq3Z_1e0NHrSsdPLodXcr3lDgKrWTv3nDcTzTflPOyWrWc=
qUoXKLt199CeDsHi8dUv5IarBitBdUvD2tTHD280bMlC7C4QLQMHnO8APE8gljCUkHmuVnB23Vi=
6ic99D5aFiR2-ZQIfS6ky__3gxT/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h19/h001.p3OR_WR5nIg=
2z90fqaNCCo_WmJoKjjlW-Sr68pu6s7o" target=3D"_blank" rel=3D"noopener norefer=
rer nofollow"><span>Peptide Cheat Sheet</span></a></span></p></li></ul></di=
v></td></tr><tr><td id=3D"all-my-daily-essentials-on-amazon" class=3D"dd" a=
lign=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:normal;padd=
ing:0px 15px;text-align:left;"><h3 style=3D"color:#2A2A2A;font-weight:norma=
l;mso-line-height-alt:125.0%;"><span style=3D"font-size:1.5rem;">=F0=9F=91=
=89All my daily essentials on Amazon</span></h3></td></tr><tr><td style=3D"=
padding-bottom:12px;padding-left:37px;padding-right:27px;padding-top:12px;"=
 class=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul=
 style=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !impor=
tant;margin-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"list=
Item ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:=
left;word-break:break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"=
link" href=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5c=
nVK8eY25CRLwlRKTpVDbusob54dBmEtPlyMSi9REfkgoE34zkniyN1JVRwx3GZSh5AcdbrN5sNf=
scZEATO_pzJfI1cg4TjNQbgk5biL7sSf28lDFvdrXp-l6ZZJ719iaFRqaInVUkKJErT2GKevERn=
mM6Hhyg1IhOYV-0hONDp5RfwPxDwwb2_tE5Y5LJ_VY_JnqLkhwyKM57psNYrsD2HsiCZHDWsIEI=
rKYCZMxpzu_33R6z-kA_ZLe7jrQ9eXzk13xETl_3w6BMdhW3gsmmfM9wq_O7mWmut5Mvn40r0tD=
TW9oRJ1lh0Vkuy0yV-J-uoE8Y_8Uh4EJCKJYsf-mSFV9xcDFw9ozXbZeWzNsjIV/4oi/WhEM1KS=
9Sb6HUKtul8E7nQ/h20/h001.coRo0WFKISZ3kWQPChuh9LmKCTFUzPjYK9X8Agln23Y" targe=
t=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>Amazon Storefront</=
span></a></span></p></li></ul></div></td></tr><tr><td id=3D"get-discounts-o=
n-your-favorite-pept" class=3D"dd" align=3D"left" valign=3D"top" style=3D"c=
olor:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h3 styl=
e=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:125.0%;"><span st=
yle=3D"font-size:1.5rem;">=F0=9F=91=89Get discounts on your favorite peptid=
es and research chemicals:</span></h3></td></tr><tr><td style=3D"padding-bo=
ttom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" class=3D"=
ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"=
font-weight:normal;list-style-type:disc;margin-bottom:12px !important;margi=
n-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listItem ultex=
t"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-=
break:break-word;"><span style=3D"color:#ff0000;font-family:Verdana,Geneva,=
sans-serif;font-size:1.5rem;font-weight:700;">PEPTIDES</span></p><ul style=
=3D"list-style-type:circle;margin:0px 0px;padding:0px 0px 0px 0px;"><li cla=
ss=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;t=
ext-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">Bi=
oLongevity Labs (use code hunterw for 15% off):=C2=A0</span><span style=3D"=
font-size:1.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com/=
ss/c/u001.XBXHqIRlWD2o7jctEk3ryW8PfZZTjR9oPVnqYq_MqtnRySH0u8MUZzep7T45dQc38=
E9qddqQFazrZwcfSWyeky4j4zKQnYsIwnWAgtqmwqlXLlZxbi4itsrIZ7fDRKlvMSs-2e8mQxq5=
EHCdsgjGcuicnqw7vu2TR5aS9Uy3Rzg3hitRCrtpm5ZwUqLiTHHPIphc4jZHub0S5fkOIQ1TiDs=
JNoZ7GMxuDMRn471ORWCME6b7pI1ZX6TO9wYbNFj0/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h21/h0=
01.ws3HiDuJn6s70cEuq86uFb33CtHjZdQfE3LmsWwKAZ0" target=3D"_blank" rel=3D"no=
opener noreferrer nofollow"><span>https://biolongevitylabs.com/</span></a><=
/span><span style=3D"font-size:1.5rem;">=C2=A0</span></p></li></ul></li></u=
l></div></td></tr><tr><td id=3D"10-off-my-favorite-protein-powder-a" class=
=3D"dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:no=
rmal;padding:0px 15px;text-align:left;"><h3 style=3D"color:#2A2A2A;font-wei=
ght:normal;mso-line-height-alt:125.0%;"><span style=3D"font-size:1.5rem;">=
=F0=9F=91=8910% off the BEST workout supplements from Unmatched Supps (pre-=
workout, whey protein, creatine, EAAs, electrolytes - use code HUNTERW at c=
heckout):</span></h3></td></tr><tr><td style=3D"padding-bottom:12px;padding=
-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=3D=
"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:norma=
l;list-style-type:disc;margin-bottom:12px !important;margin-top:12px !impor=
tant;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D"ms=
o-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-word;=
"><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.=
mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5chHLhboHu6O67eTKjF4PWfeso7_p=
nUT0XbhuaV9pa8ot2lM3iNw0vbqVksSx2Qk362rf_lGssmFxDX-qwmgkndnfDQMpxt8HZizoWnU=
MjUlcP_oCexOb17zBnPrD23Eys_4WedzDC8eNOsANbIj0HnnFHu4WRmjHz-F-j2f1aOR--RGlgG=
_qfo6hDxf70xgzYpXHhzr0kuXHPXKcrs5TPUVZ9ksA4HQTfmFwuX58ZIn5K8RV31qhwZrQ0wBpU=
VF3EvCqUGJDnX0-gck-ZiKfFA4/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h22/h001.eC0xh7-CzQFj=
6bAfgBCk8Vmqyk1IIs87ArakEyqYJuE" target=3D"_blank" rel=3D"noopener noreferr=
er nofollow"><span>https://www.unmatchedsupps.com?sca_ref=3D8677061.S6mh8SO=
sogBzjOO</span></a></span></p></li></ul></div></td></tr><tr><td id=3D"submi=
t-a-video-topic-for-my-next-yo" class=3D"dd" align=3D"left" valign=3D"top" =
style=3D"color:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;=
"><h3 style=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:125.0%;=
"><span style=3D"font-size:1.5rem;">=F0=9F=91=89Submit A Video Topic For My=
 Next YouTube Video:</span></h3></td></tr><tr><td style=3D"padding-bottom:1=
2px;padding-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><d=
iv style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-w=
eight:normal;list-style-type:disc;margin-bottom:12px !important;margin-top:=
12px !important;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p =
style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:=
break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"ht=
tps://link.mail.beehiiv.com/ss/c/u001.KRi0pFg1TnB-L5Xr4VTHbbemRY94TuUuyD0VE=
5omxSc2SjqVacq5qi_4g0zj8XDarQBkGZiWZ-Nfn6Sk_87h8y_3KNE0hxfAv4Sg3vbH5EQidQJP=
Nk0Rt-PlaE_9CrIWHYfrEuNJA5MWAUO5NYxlSAG2fXRVA2EJp1tK6d39bDA6uhWffmN4hE6lfo6=
8xu7PU5PPGAdJeTBN5TCfPdMo0bZIKeQYoz6xGLSeK3CAzS9o4PnanEI7Ww1Dkh9sgZ-Tpxlm_c=
b1iub7OeZ88FTElA/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h23/h001.K-WuSBSmArMCRzbJ_d2eZz=
k8FqCUfFzE9PAPT0X5Bg0" target=3D"_blank" rel=3D"noopener noreferrer nofollo=
w"><span>https://hunterwilliamsvideotopic.carrd.co/</span></a></span></p></=
li></ul></div></td></tr><tr><td class=3D"w" align=3D"center" valign=3D"top"=
 style=3D"padding:15px 15px 15px 15px;"><table role=3D"none" width=3D"100%"=
 border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td =
align=3D"center" valign=3D"top"><p style=3D"font-family:'Verdana',Geneva,sa=
ns-serif;color:#2D2D2D!important;"> Update your email preferences or unsubs=
cribe <a class=3D"link" href=3D"https://link.mail.beehiiv.com/ss/c/u001.KRi=
0pFg1TnB-L5Xr4VTHbTUXhpH0c4aibrubwMtxLGHD31DhfnyGtZU8AZ6T-BAJdGuCacsXfIUqTd=
enm7u5wpKGaX_tXZgyK6_ie3JXweGarLcX-TkRxHhU7K3hUbohMUVMftGsM8mzVa_-sWNc06gaq=
G2CFL0rM2t9c8WukOOrKrPkxTHVF10HEd7AWsOwxidCzLnw22lJVvVxS6x_LKu9sCAYDeTgENn1=
RGo82aOhzqnuZoOMr_pVFPVRt77XGPCjjw7Ef0716hq5hvxHU2BvOtmSq4Z7-dvlzGXiTeMgErN=
0lt-n48lUmkNPggL76CCZsX195PfbmNurLMAKr_HCOSggSR1sl0x5awtjx1kqz9lceMbUoXS_mE=
Vyce13rj4uqwkf8d1acggKd6FtRrTxbJlsv5OGSiGnGp6jDzrXSpboUof7P5UFx5H5VtQB50GMR=
c76t5RDBhwyiSqzP6g3eRETIPA9FKo77Q1Bo0Jr6y-ITTSLyFn1THiQkjunbTbLo6g2fXWHVOL7=
cw1dXkrsacZcJBKyf-9E5YKjoMJ_WqJDgkuPYTNBZEukIQ5fbrq_U8Gql585eGqoH6Yo8ZwG_53=
4xe1VDzhMqN1vsQRNugZx_NwizvVLUH7wQGifLTaC2-jrNw4Bm8fJGf8w4eIW2VRbZesC6CMYgF=
cIG_R3S9noLqhRndgkNHpDwtoybr1uWAQ35Lz3IenF9y1YBhW0XDn6wS3WCgSPQqUFgPQtna0GO=
yH32Y5trQG-focrzTWPqFmO_4uI6c7teTjofeLlrnru0IBJLd_APen10KopGPNtELKgV6rq3V_-=
mmz6v0UgQc-cZPP9AgxIJaoeYTSbw2C8LxfdWPy8ty6U4JneFdufzLXYsjpMbkqHD7ZVPmIupu9=
3JRUbY95afKrdbuo-9Bkb17uMzz_H_kLvOxaEo1DYh_UPBQ4gijpL0uKI8gduxLtOV4GkY9CVrW=
302rpch_5RW1WkQ_c7qPZKLLPUx4HAG5YXNRxOROJYvA-PfptZowGMN08mHG1rvWdJqRHLVsMWe=
gJ0LS44ghe8aVE/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h24/h001.m31sm9cI3pG_kKJnnUa1twUh=
jZDmmRAqBF5E2kV0j7Y" style=3D"text-decoration:underline;text-decoration-col=
or:#2D2D2D!important;color:#2D2D2D!important;"> here</a></p><p class=3D"cop=
yright" style=3D"font-family:'Verdana',Geneva,sans-serif;color:#2D2D2D!impo=
rtant;"> &copy; 2026 Hunter&#39;s Health Hacks </p><p style=3D"font-family:=
'Verdana',Geneva,sans-serif;color:#2D2D2D!important;"> 228 Park Ave S, #299=
76, New York, New York 10003, United States </p></td></tr><tr style=3D"disp=
lay: table-row !important;"><td align=3D"center" valign=3D"top" style=3D"pa=
dding-top:20px;" style=3D"display:table-cell !important;"><table role=3D"no=
ne" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center" style=
=3D"display:table !important;"><tr style=3D"display:table-row !important;">=
<td class=3D"u" align=3D"center" valign=3D"middle" height=3D"32" style=3D"h=
eight:32px;display:table-cell !important; max-height: 32px !important;margi=
n:0px !important; background-color: #ffffff !important;"><a style=3D"line-h=
eight:32px !important;text-decoration:none;display:block !important;" href=
=3D"https://link.mail.beehiiv.com/ss/c/u001.fw6KhFr6V_IfF6b8t1O5cpUhQFxTLaw=
3M1353wyhyd0i7984q6aP8k1mG8piU2SFI0cP2Or4b81VXr_FgaljPUlcG2f8QyaL1WEf--zQkm=
18Pum02bFpA1U07KstqMWzuPiTss3Ky97IyCwMuAglaqlpw5ZVJLWDdWEYTb1lzPM_a64uFODc2=
T7Dfj0-SZygWrc_ESlH_tyLNGBoFo5NXO75n8Le8Yx4tWeIaE2u0-XKl7oZKhjlXI-qw_p2Gyk3=
/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h25/h001.fCouJy1Mcuc5hqg2XWiRahA25jj2YBB8n4-pTR=
YHaPI"><img src=3D"https://media.beehiiv.com/output-onlinepngtools.png" wid=
th=3D"16" alt=3D"beehiiv logo" style=3D"display:inline-block !important;max=
-width:16px !important; vertical-align:-3px !important;width: 16px !importa=
nt;" border=3D"0"/><span style=3D"padding-left:11px !important;display: inl=
ine-block !important;">Powered by beehiiv</span></a></td></tr></table></td>=
</tr><tr><td align=3D"left" valign=3D"top" height=3D"2" style=3D"height:2px=
;"><a href=3D'https://link.mail.beehiiv.com/ss/c/u001.KRi0pFg1TnB-L5Xr4VTHb=
eyE1z9zPzOGRZpN3NEmiH8F4V7FFZltZmDu0zYiZmsr9XG9aUzyYeLRIMgINF_xOnmsNN-ufcR_=
nNq7U_EU86c/4oi/WhEM1KS9Sb6HUKtul8E7nQ/h26/h001.WSaWMoe6R627qDXXIOomEKwL-Oz=
XwInXdBM2Q1DEzfg' style=3D"color: #FFFFFF !important; cursor: default; font=
-size: 1px; text-decoration: none;"> Terms of Service </a></td></tr><tr><td=
 align=3D"left" valign=3D"top" height=3D"2" style=3D"height:2px;"><a href=
=3D'https://email.beehiivstatus.com/43341f4979d8ab6fc64937e54f675e854fcfcf5=
a/hclick' clicktracking=3D"off" style=3D"color: #FFFFFF !important; cursor:=
 default; font-size: 1px; text-decoration: none;"></a></td></tr></table></t=
d></tr></table></td></tr></td></tr></table></td></tr></table></td></tr></ta=
ble></td></tr></table></div></body></html>
--c6c7c7d11241dde5747f0a0c29d8e7069d0ee77b974969f31514bb7aeb57--
